Tag Archives: Health and Medical

Zeteo Biomedical Expands into Pulmonary Drug Delivery with AriesMR Active Dry Powder Inhaler

New ZTECH-P™ pulmonary platform provides active, propellant-free powder aerosolization without reliance on patient inspiratory effort and supports single- and dual-API combination products

AUSTIN, Texas, Sept. 15, 2026 (SEND2PRESS NEWSWIRE) — Zeteo Biomedical LLC today announced the expansion of its ZTECH-P™ powder drug-delivery platform into pulmonary delivery with the introduction of AriesMR™, a reloadable active dry powder inhaler designed for controlled pulmonary administration of pharmaceutical powders without reliance on patient-generated inspiratory energy for powder aerosolization or the use of CFC/HFA propellants.

Image caption: AriesMR™ Active Dry Powder Inhaler.

Unlike conventional passive dry powder inhalers that depend substantially on a patient’s inspiratory effort to disperse and aerosolize a formulation, AriesMR uses an integrated mechanical energy source to actively aerosolize and deliver the powder. The orientation-independent platform provides configurable dose and aerosolization parameters that can be optimized with formulation and particle characteristics for pulmonary delivery.

“AriesMR extends technologies we have developed and refined for nasal powder delivery into a pulmonary platform designed around many of the same challenges our pharmaceutical partners face—dose control, formulation protection, combination-product development and scalable manufacturing,” said Timothy Sullivan, Founder and Chief Executive Officer of Zeteo Biomedical.

“Importantly, the technology provides active powder aerosolization without requiring either HFA propellants or the patient’s inspiratory effort as the primary energy source for powder dispersion.”

The platform provides pharmaceutical developers with another approach to pulmonary combination-product development at a time when the industry is evaluating new inhalation technologies, including propellant-free alternatives to conventional pressurized inhaler platforms.

AriesMR incorporates replaceable unit-dose powder cartridges in a compact, mechanically actuated device, with on-board storage for up to six cartridges and a removable and replaceable mouthpiece. The device requires no battery power and is designed to operate independently of device orientation.

The platform can support single-API and dual-API configurations, including architectures in which separate powder formulations are maintained within the primary packaging until the point of delivery. This capability may enable combination-product strategies where formulation compatibility, stability or other development considerations make conventional co-formulation difficult.

AriesMR is being developed as part of Zeteo’s integrated combination-product development platform, bringing together delivery-device engineering, formulation and particle optimization, unit-dose primary packaging, product characterization and manufacturing technology. The platform is designed to support programs from early feasibility and preclinical development through clinical translation and commercial scale-up.

The expansion into pulmonary delivery builds on Zeteo’s existing ZTECH-P™ and ZTECH-L™ platforms supporting nasal, nose-to-brain, ophthalmic, sublingual and other non-invasive routes of administration.

Sullivan will participate in the IPAC-RS 2026 Nasal Innovation Forum, September 16–17 in Jersey City, New Jersey, where Zeteo will present work involving its intranasal powder delivery technology and meet with pharmaceutical and drug-delivery developers.

“Many of the formulation, device, primary-container and manufacturing challenges encountered in nasal powder development have direct parallels in pulmonary combination-product development,” Sullivan added. “The Forum provides an opportunity to discuss how those capabilities can be applied across both routes and to explore pulmonary programs where an active, propellant-free powder delivery approach may offer advantages.”

Learn more: https://zeteobiomed.com/pulmonary-drug-delivery/

ABOUT ZETEO BIOMEDICAL

Zeteo Biomedical LLC is a Cedar Park, Texas-based drug delivery technology and combination-product development company. Zeteo develops configurable delivery platforms for powder and liquid formulations across nasal, pulmonary, ophthalmic, sublingual and other non-invasive routes of administration. The company’s capabilities integrate delivery-device engineering, primary packaging, formulation and product development, in vitro characterization, manufacturing technology and commercialization support. For more information, visit Zeteo Biomedical to learn more about the AriesMR™ active dry powder inhaler: https://zeteobiomed.com/

Media Contact: Cathy Diehl, zeteo@zeteobiomed.com

MULTIMEDIA

Image link for media: https://www.Send2Press.com/300dpi/26-0915-s2p-ariesmr-300dpi.webp

Image caption: AriesMR™ Active Dry Powder Inhaler

LOGO: https://zeteobiomed.com/wp-content/uploads/2026/09/ZeteoLogo-transparent.png

NEWS SOURCE: Zeteo Biomedical LLC

This press release was issued on behalf of the news source (Zeteo Biomedical LLC), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/zeteo-biomedical-expands-into-pulmonary-drug-delivery-with-ariesmr-active-dry-powder-inhaler/

Hemophilia Association of New Jersey Unveils Bold New Brand, Redesigned Website, and Announces Its Annual Bleeding Disorders Awareness 5K Run and 1-Mile Walk

Updated logo declares HANJ is 'For All Bleeding Disorders' and the community is invited to lace up on September 13, 2026 in East Brunswick to help fund critical patient programs and bring a team to the Annual Golf Tournament on September 28, 2026

EAST BRUNSWICK, N.J., July 23, 2026 (SEND2PRESS NEWSWIRE) — The Hemophilia Association of New Jersey (HANJ), a nonprofit 501(c)(3) organization dedicated to improving the lives of individuals affected by hemophilia and other bleeding disorders, proudly serves patients and families throughout the Garden State. Today, HANJ is thrilled to announce three exciting milestones: a refreshed logo, a completely redesigned website, and the return of its signature fundraising event: the Bleeding Disorders Awareness 5K Run & 1-Mile Walk on Sunday, September 13, 2026, at the East Brunswick Community Arts Center in East Brunswick, NJ.

Image caption: Hemophilia Association of New Jersey.

A NEW LOOK THAT SPEAKS TO EVERYONE

HANJ’s updated logo now features the phrase “For All Bleeding Disorders” marking an important step forward in the organization’s ongoing commitment to supporting every person and every family touched by a bleeding disorder here at HANJ.

The accompanying website redesign at https://hanj.org/ delivers a faster, more intuitive experience with improved access to resources, educational materials, community events, advocacy initiatives, and membership information; all designed to connect and empower the bleeding disorders community statewide.

From the Executive Director:

“We are thrilled to unveil our new logo and launch our new website,” said Stephanie Lapidow, HANJ Executive Director. “Our goal is to reach and support as many bleeding disorders patients and families as possible. Thanks to the generosity of our donors and volunteers, we proudly provide critical insurance assistance, educational programming, community-building opportunities, and strong advocacy efforts for our members throughout New Jersey. We encourage families to visit our website, learn more about our programs and services, and become members so they can join us in advancing our mission.”

LACE UP FOR A CAUSE — SEPTEMBER 13, 2026

Mark your calendars! HANJ’s annual Bleeding Disorders Awareness 5K Run & 1-Mile Walk returns on Sunday, September 13, 2026. Whether you’re a seasoned runner, a family looking for a fun morning out, or someone who simply wants to show support, there is a place for you:

5K Run — $35 ($20 for students ages 7–18)

1-Mile Walk — $25 ($15 for students ages 7–18)

Kids Under 7 — FREE

Volunteers — Sign up to help make the day a success!

Where: East Brunswick Community Arts Center, 721 Cranbury Road, East Brunswick, NJ 08816

When: Sunday, September 13, 2026 | 9:00 AM – 12:00 PM EDT

Register today, form a team and raise funds, or make a donation at: https://runsignup.com/Race/NJ/EastBrunswick/HemophiliaRunWalk.

Early registration pricing is available through July 20, 2026 — don’t wait!

WHY IT MATTERS

Every dollar raised fuels HANJ’s life-changing programs: emergency financial assistance, insurance navigation support, educational programming, Medic Alert identifications, scholarships, member advocacy, and so much more. These events bring together patients, families, healthcare professionals, advocates, and supporters from across New Jersey.

The 5K Run & Walk joins HANJ’s annual golf tournament on the fundraising calendar. Check out the tournament and save the date: https://hanj.org/event/dennis-keelty-memorial-golf-classic/.

Together, these events generate the critical funding that keeps HANJ’s programs running and its doors open for every family that needs them.

GET INVOLVED

Visit https://hanj.org/ to explore the new site, become a member, and discover how you can make a difference. Through its continued dedication to advocacy, education, and patient support, HANJ remains committed to strengthening the lives of individuals and families affected by bleeding disorders.

MEDIA ONLY CONTACT
Genevieve Christo
Hemophilia Association of New Jersey
info@hanj.org
732-249-6000

NEWS SOURCE: Hemophilia Association of New Jersey

This press release was issued on behalf of the news source (Hemophilia Association of New Jersey), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/hemophilia-association-of-new-jersey-unveils-bold-new-brand-redesigned-website-and-announces-its-annual-bleeding-disorders-awareness-5k-run-and-1-mile-walk/

3Aware and John Snow Labs Announce Partnership to Deliver Multimodal De-Identification Inside the 3Aware Evidence Vault

INDIANAPOLIS, Ind. and LEWES, Del., July 22, 2026 (SEND2PRESS NEWSWIRE) — 3Aware today announced a formal partnership with John Snow Labs to embed their world-class multimodal de-identification capabilities directly within the 3Aware Evidence Vault, enabling health systems to unlock governed, privacy-protected real-world clinical data for scalable research and commercialization—while keeping data and analytic processing inside the provider environment.

Image caption: 3Aware and John Snow Labs Announce Partnership to Deliver Multimodal De-Identification Inside the 3Aware Evidence Vault.

The partnership combines 3Aware’s Evidence Vault model, built to activate longitudinal, multimodal clinical data under each health system’s strict governance and controls, with John Snow Labs’ in-environment de-identification technology for multimodal clinical data, including structured data and unstructured EHR data, PDFs, DICOM, FHIR, and text reports. John Snow Labs’ capabilities—available at no charge to 3Aware’s healthcare provider data partners—are integrated directly into 3Aware’s native data curation and transformation workflow. Together, the companies will help health systems operationalize HIPAA Expert Determination workflows, preserve longitudinal linkage through consistent tokenization, and accelerate the creation of research-ready cohorts without moving raw patient data outside institutional control.

With this foundation in place, 3Aware can scale in silico, non-interventional observational studies by more easily surfacing and interpreting the longitudinal clinical context embedded across complete episodes of care, including the unstructured clinical narrative that structured coding and claims typically miss. Faster de-identification via John Snow Labs reduces the time needed to onboard new health system partners and produce research-ready datasets—supporting both internal KOL-led research and life sciences-funded research collaborations at greater scale—within the 3Aware Evidence Vault. As 3Aware expands from industry-sponsored evidence programs to support investigator-led research within academic medical centers, the combined solution accelerates comparative effectiveness research (CER) and value analysis across interventions, pathways, procedures, and patient subgroups.

“This partnership advances our core principle: health systems shouldn’t have to choose between protecting patient privacy and unlocking meaningful evidence,” said William (Bill) Moss, CEO of 3Aware. “By integrating John Snow Labs’ multimodal de-identification inside the 3Aware Evidence Vault, we’re making it easier for providers to participate as Commercial Data Partners—safely generating scalable, defensible real-world evidence and enabling new, non-reimbursement revenue through governed research collaboration.”

“As healthcare organizations move from pilot projects to scalable secondary use, the ability to de-identify multimodal clinical data where it lives is foundational,” said David Talby, CEO, John Snow Labs. “Partnering with 3Aware brings our de-identification capabilities into a federated evidence infrastructure designed for real operational constraints: governance, auditability, and reliable outputs.”

“For health systems, de-identification is one of the biggest determinants of whether secondary-use research can scale responsibly,” said Neil Martin, former Chief Quality Officer of Geisinger, former Chief Medical Officer of Providence Southern Division, and 3Aware Strategic Advisory Board Member. “Having trusted, world-class multimodal de-identification capabilities embedded directly within the 3Aware Evidence Vault helps mitigate risk and accelerates the ability to participate, so health systems can unlock research value while maintaining the privacy protections and governance patients and institutions expect.”

ABOUT 3AWARE

3Aware provides a Clinical Scientific Workbench and Evidence Vault that enable health systems to generate real-world evidence from longitudinal clinical records—structured and unstructured—processed within the health system’s secure cloud. The platform supports rapid cohort definition, preserves full episode-of-care context, and uses interpretive AI to surface determinant clinical signals for defensible analysis. This model strengthens investigator-led research within partner institutions and enables MedTech manufacturers to run in silico, non-interventional observational studies on devices as used at the point of care. Today, 3Aware supports 15 leading manufacturers, including Medtronic®, Johnson & Johnson®, Boston Scientific®, Stryker®, BD®, Zimmer Biomet®, CONMED®, and Teleflex®. See https://3aware.ai/ for more information.

ABOUT JOHN SNOW LABS

John Snow Labs is a healthcare AI company whose medical language models are used by 500+ enterprise customers across health systems, payers, life sciences organizations, and government agencies. Its de-identification platform removes PHI from structured data, clinical notes, FHIR, PDFs, DICOM, and SVS images, with regulatory-grade accuracy, validated across billions of patient notes and in peer-reviewed research. All processing runs inside the customer’s secure environment: no data leaves institutional control, and every pipeline produces confidence scores and audit logs that meet HIPAA Expert Determination standards. John Snow Labs also provides clinical NLP, medical LLMs, OMOP harmonization, and terminology services that let healthcare and life sciences teams build production-grade data pipelines without moving raw patient records off-premises. See https://www.johnsnowlabs.com/ for more information.

MEDIA CONTACTS
Phil Stoltzfus
VP, Marketing & Public Relations, 3Aware
info@3aware.ai

Kateryna Lee
Head of Marketing, John Snow Labs
kateryna@johnsnowlabs.com

LOGO link for media: https://Send2Press.com/300dpi/26-0722-s2p-3awarejsl-300dpi.webp

NEWS SOURCE: 3Aware

This press release was issued on behalf of the news source (3Aware), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/3aware-and-john-snow-labs-announce-partnership-to-deliver-multimodal-de-identification-inside-the-3aware-evidence-vault/

New Memoir ‘Me, Mom & the Monster’ Shines Light on Huntington’s Disease

SOUTH SURREY, British Columbia, July 16, 2026 (SEND2PRESS NEWSWIRE) — Author Corinne Brown releases her deeply personal memoir, “Me, Mom & the Monster: Our Dance Through Huntington’s Disease,” a powerful and intimate account of one family’s experience living with a devastating genetic illness. ISBN: 978-1834383958, released June 2, 2026 by Tellwell Publishing.

Image caption: New Memoir ‘Me, Mom & the Monster’ Shines Light on Huntington’s Disease.

Huntington’s disease (HD) is a rare, inherited neurodegenerative disorder that affects movement, cognition, and mental health. The book is dedicated to increasing understanding, reducing stigma, and supporting individuals and families impacted by the condition, while sharing her and her mother’s story.

In “Me, Mom & the Monster,” Brown recounts the moment her mother, Mae, received life-altering news: she had inherited the gene for Huntington’s disease. What follows is a candid and emotionally resonant narrative told through alternating voices of mother and daughter, offering readers an unfiltered look at the physical, emotional, and generational impact of the disease.

Blending memoir with raw storytelling, the book explores not only the progression of HD, but also the enduring strength of family, identity, and love in the face of uncertainty. From Mae’s life as a farming wife, businesswoman, and mother, to Corinne’s own journey alongside her, the story reveals the profound realities behind a diagnosis that affects entire families—not just individuals.

“This book offers a humbling opportunity for us to consider the impact of illness as an extension of the human condition,” says Dr. John Diggle, Clinical Assistant Professor of Neuroscience at the University of British Columbia. “It provides keen insight into not only our individual patients’ struggles, but how the impact of illness can span generations, and the power of family in the provision of care.”

The memoir has also received early critical acclaim. In a five-star review, Reader Views described “Me, Mom & the Monster” as “a memoir of supreme courage, extraordinary devotion, and overwhelming love,” praising Brown’s candid portrayal of one family’s experience with Huntington’s disease.

Brown, a graduate of Memorial University of Newfoundland and Mount Royal University’s journalism program in Calgary, Alberta, brings a lifelong passion for storytelling to her debut book. Now based in South Surrey, British Columbia, she draws on her personal experience and narrative skill to shed light on a condition that remains widely misunderstood.

As awareness efforts continue worldwide, “Me, Mom & the Monster” arrives as both a contribution and a compassionate call to better understand Huntington’s disease and those it affects.

“Me, Mom & the Monster: Our Dance Through Huntington’s Disease” is available now.

About the Author

Corinne Brown is a Canadian author based in South Surrey, British Columbia. Originally from Newfoundland & Labrador, she holds a Bachelor of Arts from Memorial University and a journalism diploma from Mount Royal University in Calgary, Alberta. A lifelong storyteller, “Me, Mom & the Monster” is her first published work.

BOOK DETAILS
Title: Me, Mom & the Monster: Our Dance Through Huntington’s Disease
Author: Corinne Brown
Website: https://corinnebrown.ca/
Genre: Memoir
Release Date: June 2, 2026
Paperback ISBN: 978-1834383958
Purchase Link: https://amazon.com/dp/1834383951

BOOK IMAGE for media: https://corinnebrown.ca/wp-content/uploads/2026/06/me-mom-and-the-monster-book-by-author-corinne-brown-6.png

NEWS SOURCE: Tellwell Publishing

This press release was issued on behalf of the news source (Tellwell Publishing), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/new-memoir-me-mom-the-monster-shines-light-on-huntingtons-disease/

New Cadence Healthcare Welcomes Dr. Karen Rasmussen as Third Physician, Reuniting Three Doctors from the Same Long Beach Residency Program

Dr. Rasmussen joins founding physician Dr. Cordelia Sotelo and Dr. Jasia Hu in August 2026 - all three trained at MemorialCare Long Beach Medical Center's family medicine residency program

LONG BEACH, Calif., July 2, 2026 (SEND2PRESS NEWSWIRE) — New Cadence Healthcare, a membership-based primary care practice in Long Beach, today announced that Dr. Karen Rasmussen will join the practice as its third physician beginning August 2026.

Image caption: Dr. Karen Rasmussen.

Dr. Rasmussen is a board-certified family physician who has cared for patients in Southern California for more than a decade. Since 2011, she has practiced comprehensive outpatient family medicine at Optum’s Orange County location in Los Alamitos. She earned her Bachelor of Science in Biology from the University of California, Irvine, where she was part of the Campuswide Honors Program and was inducted into Phi Beta Kappa. She then completed her medical degree at the University of Cincinnati College of Medicine before returning to Southern California to complete her family medicine residency at MemorialCare Long Beach Medical Center, the same program where Dr. Sotelo and Dr. Hu trained.

Her arrival brings capacity for up to 300 new patients to a practice model that caps each physician’s panel at 300 — roughly one-fifth the load carried by physicians in traditional insurance-based primary care.

“I am joining New Cadence because I want to be able to practice medicine the way it should be practiced,” said Dr. Rasmussen. “Longer visits that aren’t rushed, better availability, responding promptly to patients when they reach out, and taking the time to actually get to know them. These things are just not possible within the system most primary care physicians operate in today.”

Dr. Rasmussen joins founder Dr. Cordelia Sotelo and Dr. Jasia Hu at the practice’s Bellflower Boulevard office. Dr. Sotelo’s panel is currently full; Dr. Hu, who joined in December 2025, continues to accept new patients.

“Karen is exactly the kind of physician we built this practice for,” said Dr. Cordelia Sotelo, founder of New Cadence Healthcare. “She’s experienced, deeply patient-centered, and as committed as we are to the idea that primary care should be a relationship — not a 7-minute transaction. And there’s something meaningful about the three of us coming from the same residency program. We share a foundation of how we were trained to care for patients.”

Patients interested in establishing care with Dr. Rasmussen can learn more at https://newcadencehealthcare.com/ and call the office at 562-248-2999 to sign up.

New Cadence memberships include appointments that fit your schedule, a direct line to your care team where you are able to reach out to us anytime by phone or through a secure online patient portal with same-day or next-day replies, and care coordination with specialists.

About New Cadence Healthcare

New Cadence Healthcare is a membership-based primary care practice located at 1777 N Bellflower Blvd, Suite 210, in Long Beach, California. The practice was founded by Dr. Cordelia Sotelo to offer an alternative to the time-constrained primary care most patients experience inside the insurance system. Each New Cadence physician caps their panel at 300 patients, allowing for longer visits, direct access, and a deeper patient-physician relationship.

Dr. Karen Rasmussen is board certified by the American Board of Family Medicine and an active member of the American Academy of Family Physicians.

MEDIA CONTACT:
Name: Lauren Osborne
Email: Lauren@lhoandco.com
Phone: 562.232.4375

NEWS SOURCE: New Cadence Healthcare

This press release was issued on behalf of the news source (New Cadence Healthcare), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/new-cadence-healthcare-welcomes-dr-karen-rasmussen-as-third-physician-reuniting-three-doctors-from-the-same-long-beach-residency-program/

NeuroDex ExoSORT Platform Demonstrates Treatment-Responsive Blood-Based Measurement of Neuronal TDP-43 in People Living with ALS

NeuroDex's neuron-derived extracellular vesicle (NDE) technology measured neuron-specific TDP-43 in blood samples

NATICK, Mass., July 1, 2026 (SEND2PRESS NEWSWIRE) — NeuroDex, a precision diagnostics company specializing in the isolation and analysis of neuron-derived extracellular vesicles (NDEs) from blood, today announced new findings supporting NDE-associated TDP-43 as a treatment-responsive biomarker in amyotrophic lateral sclerosis (ALS).

Image caption: NeuroDex Inc.

TDP-43 mislocalization and aggregation occur in more than 97% of ALS cases, about 40% of frontotemporal dementia and a substantial proportion of Alzheimer’s-spectrum disease, either as co-pathology or primary pathology (Limbic-predominant Age-related TDP-43 Encephalopathy,LATE). Despite its central role across neurodegenerative diseases, reliable biofluid biomarkers capable of measuring TDP-43 pathology in living patients have been elusive.

Conventional plasma TDP-43 measurements are limited by substantial biological background, as TDP-43 is expressed throughout the body and detected from numerous peripheral cell types. NeuroDex’s proprietary ExoSORT™ platform addresses this challenge by selectively enriching neuron-derived extracellular vesicles from blood, providing a minimally invasive window into molecular processes occurring within neurons of the brain and spinal cord.

Across multiple independent cohorts, ExoSORT-based analysis demonstrated that NDE-associated TDP-43 distinguished sporadic ALS from healthy controls. These findings were reproduced across three cohorts: 75 sporadic ALS versus healthy controls (44% increase, P=0.0003); 25 sporadic ALS versus 30 healthy controls (52% increase, P=0.002); and a third cohort of 52 ALS versus 37 healthy controls, in which NDE-associated TDP-43 was markedly elevated in disease (more than twofold higher; P<0.0001).

Longitudinal analyses further showed that NDE-associated TDP-43 increases over time as disease progresses. In the most recent cohort, NDE-associated TDP-43 rose over time in sporadic ALS and tracked clinical status. Within-patient longitudinal modeling estimated an increase of approximately 45% per year in sporadic ALS, and TDP-43 levels were associated with disease severity as measured by the ALSFRS-R.

“TDP-43 is emerging as a central pathology in neurodegeneration, yet measuring it in biofluids has been a long-standing challenge. A blood-based readout of TDP-43 could enable better patient selection and treatment monitoring and make clinical trials more efficient. These data are encouraging and support moving into clinical validation,” said Dr. Ajay Verma, CEO of Twilight, which works with NeuroDex to develop TDP43 biomarkers for ALS and FTD.

TDP43 can also serve as a treatment response biomarker. In a recent phase 2b randomized, placebo- controlled clinical trial (PARADIGM) conducted by NeuroSense Therapeutics (Nasdaq: NRSN) with its lead product candidate PrimeC (Cudkowicz et al. 2026), NeuroDex applied its ExoSORT workflow to serial samples collected longitudinally from study participants across all scheduled study visits. NDE-associated TDP-43 was measured in serial blood samples obtained throughout the trial, enabling assessment of biomarker trajectories over time in both placebo-treated and actively treated participants.

In this trial, NDE-associated TDP-43 increased over time in the placebo group, consistent with the natural-history pattern observed in NeuroDex’s prior studies. In contrast, participants receiving PrimeC demonstrated a statistically significant reduction in NDE-associated TDP-43 from baseline over the 6-month treatment period.

Notably, the biomarker analyses were derived from the same randomized clinical dataset that demonstrated favorable effects on functional decline, survival, and additional disease-relevant biomarkers. Taken together with NeuroDex’s prior work, these findings strengthen the evidence linking NDE-associated TDP-43 to ALS disease biology and support its continued evaluation in clinical studies as a pharmacodynamic biomarker.

The analysis was performed using NeuroDex’s ExoSORT platform, the first automated and scalable technology designed specifically for enrichment of neuron-derived extracellular vesicles from blood samples “In our Phase 2b PARADIGM clinical trial, PrimeC demonstrated a meaningful slowing of disease progression and an improvement in survival. The opportunity to pair that clinical effect with a blood-based measure of TDP-43 pathology is an important step toward understanding treatment effects on the underlying biology,” said Alon Ben-Noon, Chief Executive Officer of NeuroSense Therapeutics.

Dr. Erez Eitan, NeuroDex CEO added “We are excited to see NDE-associated TDP-43 distinguish disease from healthy controls and change over time in ALSThese results demonstrate the power of our NDE technology to take pathological proteins with broad tissue expression and transform them into neuron-specific biomarkers.”

ABOUT EXOSORT™ AND NEURON-DERIVED EVS

ExoSORT™ is NeuroDex’s proprietary automated platform for the enrichment of neuron-derived extracellular vesicles (NDEs) from blood samples. Using a combination of highly specific neuronal antibodies and a scalable 96-well workflow, ExoSORT™ selectively isolates extracellular vesicles originating from the brain, increasing the neuronal signal by more than 50-fold compared with conventional plasma analyses. By enriching for brain-derived vesicles, ExoSORT™ enables detection of disease-associated proteins that are also present in other tissues, such as TDP-43.

ABOUT NEURODEX

NeuroDex is a precision diagnostics company focused on unlocking the central nervous system through the analysis of neuron-derived extracellular vesicles isolated from blood. Its proprietary ExoSORT™ platform enables researchers and drug developers to measure brain-specific proteins and biomarkers from a routine blood draw, supporting earlier detection, target-engagement readouts, and treatment-response monitoring across neurodegenerative diseases including ALS, Alzheimer’s disease, and Parkinson’s disease.

ABOUT ALS

Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease that causes progressive paralysis and is typically fatal within 2–5 years of diagnosis. More than 5,000 people are diagnosed with ALS each year in the U.S. alone, with an estimated annual disease burden of $1 billion. The number of people living with ALS is expected to grow by approximately 24% by 2040 across the U.S. and EU.

ABOUT NEUROSENSE PRIMEC

PrimeC, NeuroSense Therapeutics’ lead drug candidate, is a novel extended-release oral formulation combining two FDA-approved drugs, ciprofloxacin and celecoxib, in a unique fixed-dose combination. PrimeC is designed to synergistically target several mechanisms implicated in ALS, including neuroinflammation, iron accumulation, and impaired RNA regulation, with the goal of slowing disease progression.

MEDIA CONTACT

NeuroDex — Email: info@neurodex.co

https://neurodex.co

Forward-Looking Statements
This press release contains “forward-looking statements” that are subject to risks and uncertainties. Statements regarding the future application of the ExoSORT™ platform, the development of PrimeC, the timing and outcome of clinical trials including a potential Phase 3 (PARAGON) study, and regulatory engagement are forward-looking and based on current expectations. Biomarker findings described herein are exploratory, were generated in part in collaboration with NeuroSense Therapeutics Ltd., and require confirmation in additional studies. Actual results could differ materially from those anticipated. For additional information regarding NeuroSense, PrimeC, and the PARADIGM study, refer to NeuroSense’s filings with the U.S. Securities and Exchange Commission. NeuroDex undertakes no duty to update forward-looking statements except as required by law.

NEWS SOURCE: NeuroDex Inc.

This press release was issued on behalf of the news source (NeuroDex Inc.), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/neurodex-exosort-platform-demonstrates-treatment-responsive-blood-based-measurement-of-neuronal-tdp-43-in-people-living-with-als/

Jabber Jaw Kids Toothpaste, LLC Introduces ‘Smile Paint’ – A Play-Based Toothpaste Concept That Turns Toothbrushing into a Creative Adventure

TAMPA, Fla., June 25, 2026 (SEND2PRESS NEWSWIRE) — Jabber Jaw Kids Toothpaste, LLC is proud to announce the launch of Smile Paint™, a revolutionary, one-of-a-kind child’s toothbrushing concept, designed to transform daily brushing into a fun, engaging experience. With its playful, hands-on approach, Smile Paint empowers kids to explore toothbrushing in a way that turns an everyday routine into a creative adventure. Smile Paint’s play-based approach is a game changer – encouraging independence, creativity, and positive oral care habits from an early age.

Image caption: Smile Paint is a revolutionary child’s toothbrushing concept designed to transform daily brushing into a fun, engaging experience.

Smile Paint offers 4 yummy, dessert-inspired, colorful toothpaste flavors including Fluoridated Vanilla Cupcake, and 3 Fluoride-free flavors including Strawberry Shortcake, Banana Cream Pie and Blueberry Cobbler. Kids mix, paint and brush while having fun creating limitless color and flavor combinations, turning toothbrushing time into something to look forward to.

Smile Paint founder and CEO Stacey Moore Thomas, a special-needs advocate, witnessed through her Tampa-based pediatric speech and language therapy company, Jabber Jaw Kids, LLC, how toothbrushing can become a daily challenge – especially for special needs children with oral sensitivities or taste aversions.

According to Thomas, “I saw the need to make the process of toothbrushing fun—one that works with a child’s natural learning style—play. With Smile Paint, kids take control by mixing the flavors and colors to create new colors and taste experiences while ‘painting’ and then brushing their teeth. It transforms resistance into excitement and fun.”

Image caption: Smile Paint Founder and CEO Stacey Moore Thomas.

In addition to 4 primary-color, flavored toothpastes, the highly innovative Smile Paint Kit includes a paint palette for limitless blending of the toothpaste color and flavor combinations, bamboo toothbrush, painting brush, and art smock. Kids can paint each tooth in different colors of their own creation prior to brushing.

Thomas went on to say, “Our toothpastes were crafted with carefully selected ingredients including all-natural flavors, mostly naturally-derived colors, and without SLS, gluten and other unnecessary additives, with a goal of prioritizing both safety and fun.”

“Our mission is simple,” Thomas added, “We want to transform toothbrushing into a fun experience that children enjoy—and that parents can feel good about.”

“From the Jabber Jaw Kids family to yours, Smile Paint is more than just toothpaste – it’s an invitation to create joyful routines, spark imagination, and share moments of silly fun and ‘rainbow smiles.’ By making brushing interactive, it helps reduce stress for families and builds confidence in children,” said Thomas.

ABOUT JABBER JAW KIDS TOOTHPASTE, LLC

Jabber Jaw Kids Toothpaste, LLC is dedicated to creating thoughtfully designed oral care products that support children’s development through play. Founded by Stacey Moore Thomas, the company blends professional insight with real-life parenting experience to bring innovative solutions to families everywhere. Every product has been designed with growing smiles in mind, ensuring a gentle, effective and fun toothbrushing experience. Learn more at: https://smilepainttoothpaste.com/pages/about.

The Smile Paint Toothbrushing Kit is available for purchase at: https://smilepainttoothpaste.com/.

Smile Paint is a trademark of Jabber Jaw Kids Toothpaste, LLC, a Tampa-based company.

MULTIMEDIA:

Image links for media:

[1] https://www.Send2Press.com/300dpi/26-0625-s2p-smilepaint01-300dpi.webp

Image caption: Smile Paint is a revolutionary child’s toothbrushing concept designed to transform daily brushing into a fun, engaging experience.

[2] https://www.Send2Press.com/300dpi/26-0625-s2p-smilepaint02-300dpi.webp

Image caption: Smile Paint Founder and CEO Stacey Moore Thomas.

LOGO (white): https://smilepainttoothpaste.com/cdn/shop/files/Smile-Paint-Logo-Marshmellow.png

NEWS SOURCE: Jabber Jaw Kids Toothpaste LLC

This press release was issued on behalf of the news source (Jabber Jaw Kids Toothpaste LLC), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/jabber-jaw-kids-toothpaste-llc-introduces-smile-paint-a-play-based-toothpaste-concept-that-turns-toothbrushing-into-a-creative-adventure/

Florida Attorney General Uthmeier Becomes First in Nation to Subpoena CVS’s Secret Contracts with Drug Manufacturers, Distributors, and Pharmacies

Landmark Action Aims to Expose Opaque PBM Practices Driving Up Drug Costs and Threatening Independent Pharmacy Access

TALLAHASSEE, Fla., June 25, 2026 (SEND2PRESS NEWSWIRE) — Small Business Pharmacies Aligned for Reform (SPAR) today praised Florida Attorney General James Uthmeier for becoming the first attorney general in the United States to subpoena CVS’s confidential contracts with drug manufacturers, wholesale distributors, and both chain and independent retail pharmacies. The subpoenas represent a historic step toward exposing the secretive pricing and contracting practices of pharmacy benefit managers (PBMs) that patient advocates and independent pharmacists say have driven up prescription drug costs and jeopardized patients’ access to community pharmacy care.

Image caption: Small business Pharmacies Aligned for Reform (SPAR) is a group of Floridian neighborhood pharmacists and other advocates.

“We appreciate Attorney General Uthmeier for standing up to CVS and the vertically integrated PBMs on behalf of Floridians seeking answers to the continuing problems of ever-increasing price and shrinking patient accessibility to prescription medication,” said Dawn Butterfield, SPAR president. “Floridians are entitled to know and understand how PBM contract terms may affect their access to care and the price they pay at the pharmacy counter.”

“The subpoenas will compel CVS to produce contracts that have never been subject to public scrutiny, including agreements governing drug pricing with manufacturers, wholesaler purchase terms, and the reimbursement and network participation conditions imposed on retail pharmacies,” said Barney Bishop, SPAR’s CEO. “Transparency into these agreements will allow investigators to assess whether CVS’s contracting practices comply with state consumer protection and antitrust law, and whether patients are being harmed by the systemic elimination of independent pharmacy competition.”

“SPAR urges state attorneys general across the country to follow Florida’s lead and examine whether PBM contracting practices in their states are harming patients and independent pharmacies,” Mr. Bishop said.

ABOUT SPAR

Small business Pharmacies Aligned for Reform (SPAR) is a group of Floridian neighborhood pharmacists and other advocates focused stopping anti-competitive practices that PBMs use to short circuit the free market while placing additional burdens on patients and pharmacists. SPAR is committed to championing legislation that promotes neighborhood pharmacies’ ability to continue providing medications and care to the local patients and communities they serve. Learn more: https://www.sparfl.org/

REF: https://www.myfloridalegal.com/newsrelease/attorney-general-james-uthmeier-issues-subpoena-cvs-health-corporation-and-caremark

NEWS SOURCE: Florida Small Business Pharmacies Aligned for Reform (SPAR)

This press release was issued on behalf of the news source (Florida Small Business Pharmacies Aligned for Reform (SPAR)), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/florida-attorney-general-uthmeier-becomes-first-in-nation-to-subpoena-cvss-secret-contracts-with-drug-manufacturers-distributors-and-pharmacies/

Simpson Spotlights a More Connected Approach to Memory Care for Alzheimer’s and Brain Awareness Month

WEST GROVE, Pa., June 25, 2026 (SEND2PRESS NEWSWIRE) — As Americans live longer, conversations about positive aging and brain health are becoming increasingly important. During Alzheimer’s & Brain Awareness Month, Simpson, a family of retirement communities in Pennsylvania, is helping normalize these discussions through educational programs and resources that empower individuals and families to approach memory care with greater understanding, confidence, and hope.

Image caption: Residents and care team members from Simpson Meadows’ neighborhoods recently attended a Phillies game together, reflecting the community’s commitment to connection, engagement, and belonging at every stage of aging.

Simpson’s Jenner’s Pond in West Grove and Simpson Meadows in Downingtown are Life Plan Communities that offer independent living, assisted living, memory care residences, rehabilitation and respite care.

The memory care programming at both communities has earned the prestigious Comfort Matters® accreditation, marking Simpson the first provider in Pennsylvania and one of only 43 worldwide to achieve the distinction. The accreditation recognizes Simpson’s commitment to providing person-directed dementia care that prioritizes comfort, dignity, and emotional well-being for individuals living with dementia.

At Simpson Meadows, memory care residents regularly take part in group outings, such as attending a recent Philadelphia Phillies game, fishing at a local fish hatchery, bowling, and miniature golf, led by Executive Director Tim McCracken.

“One of the things that’s very important at Simpson Meadows is fostering and cultivating a community that isn’t segregated by where people are in their lives. Residents from our memory care neighborhood are invited to join us on our outings and community events,” said McCracken.

From daily engagement and social connection to family education and specialized support, Simpson’s approach helps reduce fear and stigma while giving families practical guidance for the road ahead.

“Alzheimer’s and other forms of dementia touch millions of families, including my own,” said Dr. Carol McKinley, President and CEO of Simpson. “Through the thoughtful care and programming in our Simpson communities, we provide reassurance to residents and family members. We want to help people see memory support as part of the continuum of healthy aging and an opportunity to enhance safety, engagement, and quality of life. Greater understanding leads to better care, stronger support, and more compassionate communities for those living with dementia and the people who care for them.”

As part of its person-directed care model, Simpson communities use Amba, a passive, AI-enabled health monitoring solution that provides insights to help identify and prevent infections, falls, and hospitalizations. Because the technology does not record video or audio, it supports resident privacy while delivering meaningful health data.

The HeyAmba interface is accessible on a phone or tablet and allows care teams to quickly obtain resident updates through simple questions. For example, caregivers can review a resident’s sleep score from the previous night, track changes over time, and identify emerging patterns that may indicate a health concern. This passive monitoring helps support timely interventions while allowing residents to maintain their preferred daily routines.

McCracken said Amba serves as an extension of the Simpson care team, helping team members spend more time focused on resident care while also identifying changes that may signal elevated risk of falls or infections. Simpson also uses HeyAmba’s data to keep families informed and provide valuable insights for clinicians.

“It’s a continuation of our care philosophy,” McCracken said. “By alerting us when a resident gets out of bed, we can intervene and potentially prevent a fall. We can also monitor behavioral changes that may signal an infection before symptoms develop.”

Together, Simpson’s accredited memory care programming, family education, and supportive technology reflect a broader commitment to helping residents live with dignity, connection, and comfort at every stage of aging.

ABOUT SIMPSON

Since 1865, Simpson has met the changing needs and desires of Pennsylvania area seniors from diverse backgrounds as a not-for-profit family of services consisting of three Continuing Care Retirement Communities (CCRCs): Simpson House, Simpson Meadows and Jenner’s Pond; three affordable senior living communities: Simpson Gardens I, Simpson Gardens II, and Simpson Midtown; as well as Simpson HomeCare and Simpson Rehabilitation. The organization is dedicated to providing elders from diverse backgrounds with more amenities, better services, improved care, and a higher quality of life in beautiful, dignified, and spiritual settings.

For more information, visit https://www.simpsonsenior.org/.

Press Page:
https://www.simpsonsenior.org/about/press/

Image link: https://www.simpsonsenior.org/wp-content/uploads/2026/06/SM-Phillies-Trip.png

NEWS SOURCE: Simpson

This press release was issued on behalf of the news source (Simpson), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/simpson-spotlights-a-more-connected-approach-to-memory-care-for-alzheimers-and-brain-awareness-month/

Breakthrough At-Home Vision Testing Platform Reinvents the Eye Exam with MIT Science and Telehealth

California firm ProNova Partners has been retained to develop major strategic partnership and acquisition relationships for a fully developed, clinically validated, FDA-registered at-home vision-testing platform now operating in more than 150 countries

LOS ANGELES, Calif., June 23, 2026 (SEND2PRESS NEWSWIRE) — Seventeen-year-old Mergers and Acquisitions firm ProNova Partners has announced it has been retained to develop major strategic partnership and acquisition relationships for a breakthrough at-home vision-testing technology built on optical science exclusively licensed from the Massachusetts Institute of Technology.

Image caption: ProNova Partners, Inc.

The platform lets a person measure their own vision with a smartphone and receive a doctor-generated eyeglass or contact lens prescription remotely, without a clinic visit. It spans seven FDA-registered medical devices and applications, and independent clinical trials have confirmed accuracy comparable to the in-office equipment used in a traditional eye exam.

More than 50,000 devices are in use across over 150 countries, built up over eight years of operation with zero product defects and zero litigation. The technology, while not meant to replace the traditional in-clinic eye exam, carries a full regulatory and quality stack, including ISO 13485 and HIPAA compliance, and is protected by more than two dozen issued patents.

“Every so often a technology quietly solves a problem an entire industry has worked on for decades,” said Terie Salinas, Chief Operating Officer of ProNova Partners. “This is one of those. It is fully built, clinically validated, and already in use worldwide. Our mandate is to bring the right strategic partners to it.”

The technology arrives as the roughly $60-billion U.S. vision-care market faces a growing shortage of eye-care providers, and as the traditional eye exam — essentially unchanged for two centuries — becomes the next consumer-health category reshaped by telehealth and artificial intelligence.

“We have completed more than 500 transactions across many arenas, including the medical-device, healthcare, and technology space,” Salinas said. “That is exactly the experience a platform like this requires.”

Company details are available to qualified parties upon execution of a standard non-disclosure agreement.

For detailed information go to https://pronovapartners.com/engagement/patented-at-home-vision-testing-platform-for-sale/

PRESS CONTACT INFORMATION:
Terie Salinas
Chief Operating Officer
ProNova Partners, Inc.
Terie@ProNovaPartners.com
714-580-6888
https://www.pronovapartners.com/

NEWS SOURCE: ProNova Partners

This press release was issued on behalf of the news source (ProNova Partners), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/breakthrough-at-home-vision-testing-platform-reinvents-the-eye-exam-with-mit-science-and-telehealth/

New Research: Healthspan Is a Growing Priority for Senior Living

AgingIN Longevity Summit Will Explore How Communities Can Turn Longevity Science into Better Resident Outcomes

DENVER, Colo., June 11, 2026 (SEND2PRESS NEWSWIRE) — AgingIN, a nonprofit advancing innovation in eldercare, is hosting a Longevity Summit that will unite leading voices in senior living, healthcare, and aging research to explore how communities can better support longer, healthier lives. Featuring keynote speaker Dr. Shelly Chadha of the World Health Organization, the summit will be held Aug. 10 and is part of AgingIN’s annual conference, Peak Purpose: Redefining How We Live and Age, which runs through Aug. 13.

Image caption: Dr. Shelly Chadha of the World Health Organization, will discuss how senior living communities can address healthspan and longevity at the “Longevity Summit: Living Longer, Living Better” on August 10, 2026, in Denver, Colo.

At the summit, Dr. Chadha will discuss the WHO’s focus on practical ways senior living organizations can operationalize healthspan principles using evidence-based frameworks. Using its Integrated Care for Older People (ICOPE) community-based approach, organizations can work to preserve functional ability through early intervention in areas such as mobility, cognition, nutrition, vision, hearing, and emotional well-being.

According to a newly released national survey from Ziegler, 85.8% of senior living leaders say healthspan will be “very important” to the next generation of residents, reflecting growing demand for communities that support mobility, brain health, independence, social connection, and preventative care. The findings point to a major shift in how operators are thinking about aging, wellness, and long-term resident engagement.

The Ziegler research found that senior living leaders most closely associate healthspan with:

Healthy aging (81.8%)
Independence (77.3%)
Mobility (74.5%)
Brain health (72.7%)
Strength and physical function (65.5%)
Social connection (53.6%)

“Closing the gap between healthspan and lifespan is one of the most important opportunities in aging today. It’s not enough to simply add years to life; we must add life to those years. This means reimagining senior living as a place where people can maintain purpose, independence, and well-being for as long as possible,” said Susan Ryan, AgingIN CEO. “At AgingIN, we are committed to helping organizations move beyond longevity as a metric and toward quality of life as the true measure of success.”

The survey also revealed that organizations are already investing in healthspan-focused initiatives, including strength and mobility programs, cognitive engagement, fall prevention, preventative health assessments, purpose-driven programming, and lifestyle interventions designed to maintain function and reduce decline.

Yet significant challenges remain. More than 60% of respondents cited workforce capacity as the biggest barrier to expanding healthspan initiatives, while nearly half identified uncertainty around cost and return on investment.

Topics at the summit include:

The global healthspan framework shaping the future of aging
Practical strategies to embed well-being into care delivery
How healthspan influences consumer preference and market relevance
Workforce well-being as a driver of retention and quality outcomes
Memory care and higher acuity applications rooted in dignity
Lifestyle interventions that help prevent decline
Innovation models that translate research into operational results
Scalable actions organizations can implement immediately

Registration is now open for interested senior living executives, clinicians, wellness leaders, operators, board members, and professionals interested in the future of aging services. To learn more and secure your spot, visit: https://aginginnovation.org/events/annual-conference/.

About AgingIN

AgingIN is a global nonprofit dedicated to being the catalyst for person-directed living and empowered cultures in the community of one’s choice. Their consulting, technical assistance, and education services empower aging services providers to implement lasting change and transformation that is meaningful and measurable. Formerly known as the Center for Innovation, AgingIN was born from the merging of two of the most influential voices in eldercare transformation: Pioneer Network and THE GREEN HOUSE® Project. For more information, visit: https://aginginnovation.org/.

MULTIMEDIA

Image links for media:

World Health Organization logo: https://www.Send2Press.com/300dpi/26-0611-s2p-whologo-300dpi.webp

AgingIN logo: https://aginginnovation.org/wp-content/uploads/2025/07/AgingIN_logo_rgb-1.png

NEWS SOURCE: AgingIN

This press release was issued on behalf of the news source (AgingIN), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/new-research-healthspan-is-a-growing-priority-for-senior-living/

Natural Transplants and Cherry Announce Strategic Partnership and Release Exclusive 2026 Guide to Hair Transplant Cost in the U.S.

FORT LAUDERDALE, Fla., June 10, 2026 (SEND2PRESS NEWSWIRE) — Natural Transplants, a leader in physician-led hair restoration, and Cherry, a leading patient financing platform, today announced a strategic partnership aimed at improving access to high-quality hair transplant procedures nationwide. Alongside the partnership, the companies released an exclusive 2026 guide to hair transplant cost in the U.S., offering new insight into the significant cost disparities patients face across major metropolitan markets.

Image caption: Methodology: Data reflects Q1 2026 requested financing amounts from specialty hair restoration practices partnered with Cherry Technologies, Inc. While a strong indicator of total procedure costs, figures exclude unfinanced, out-of-pocket payments.

Drawing from Q1 2026 financing request data submitted through Cherry’s network of specialty hair restoration practices, the report reveals substantial regional variation in hair transplant pricing throughout the United States. According to the data, Los Angeles ranks as the nation’s most expensive market, with average procedure costs reaching approximately $15,000. By comparison, patients in Miami–Fort Lauderdale, Atlanta, and Boston reported average costs closer to $7,000. Other major metro areas fell across a wide spectrum, including Seattle at $12,250, Denver at $11,874, Chicago at $10,000, and Washington, D.C. at $8,400.

The findings underscore a growing challenge within the aesthetic medical industry: where a patient lives can significantly impact both affordability and access to care.

“Patients should never have to compromise on quality because of geography or financial limitations,” said Dr. Matt Huebner. “This partnership with Cherry allows us to remove many of the traditional barriers to treatment by combining flexible financing with travel support programs that make world-class hair restoration more accessible to patients nationwide.”

Through the partnership, Natural Transplants will continue offering travel incentives for patients visiting its flagship clinics in Fort Lauderdale and Washington, D.C., enabling individuals to prioritize surgical expertise and clinical outcomes over proximity alone. Combined with Cherry’s financing platform — which includes flexible monthly payment options, promotional 0% APR plans for qualified patients, and a soft credit check application process — patients can better manage both treatment and travel expenses.

In conjunction with this announcement, both companies have published in-depth articles to help patients better understand the financial considerations and variables involved in hair restoration:

Natural Transplants explores the full breakdown of regional pricing and what patients can expect for their investment in their comprehensive guide: How Much Does a Hair Transplant Cost (In The United States)?
Cherry provides a closer look at the specific variables influencing these prices and how accessible financing for both clinics and patients can bridge the gap in their latest post: Hair Transplant Cost: Full 2026 U.S. Pricing Breakdown

ABOUT NATURAL TRANSPLANTS

Natural Transplants is a premier hair restoration practice specializing in advanced FUE and FUT procedures designed to deliver natural-looking, long-term results. Known for its physician-led approach and commitment to clinical excellence, the company serves patients nationwide through its clinics in Fort Lauderdale and Washington, D.C. https://naturaltransplants.com/

ABOUT CHERRY

Cherry is a leading patient financing platform that helps make elective healthcare procedures more accessible through flexible monthly payment options. Designed to simplify the financing experience for both providers and patients, Cherry partners with medical practices nationwide to help individuals move forward with treatment confidently and affordably. https://withcherry.com/

MULTIMEDIA

IMAGE link for media: https://www.Send2Press.com/300dpi/26-0610-s2p-natransp-300dpi.webp

NEWS SOURCE: Natural Transplants

This press release was issued on behalf of the news source (Natural Transplants), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/natural-transplants-and-cherry-announce-strategic-partnership-and-release-exclusive-2026-guide-to-hair-transplant-cost-in-the-u-s/

Millions Dream of Having Children: World Fertility Project Expands Global ‘Break the Taboo’ Campaign to Address Stigma and Barriers to Care

International movement returns June 17, uniting voices across six continents to challenge stigma, increase awareness, and spotlight barriers to fertility care worldwide

NEW YORK, N.Y., June 10, 2026 (SEND2PRESS NEWSWIRE) — As conversations around declining fertility rates and reproductive health continue to gain global attention, the World Fertility Project (WFP), produced by pregnantish, today announced the return of its international “Break the Taboo” campaign, launching June 17 in honor of World Infertility Awareness Month.

Image caption: World Fertility Project.

Following a breakout inaugural campaign that engaged over 3 million people across six continents, the initiative returns with expanded global participation, bringing together patients, healthcare professionals, advocates, public figures, and organizations worldwide to help break the stigma surrounding infertility and increase awareness of the barriers many people face in accessing fertility care and support.

According to the World Health Organization, infertility affects approximately 1 in 6 people globally. Yet despite its prevalence, infertility remains heavily stigmatized in many communities, leaving countless individuals and couples to navigate their struggles in silence.

Listen to the pregnantish podcast “Breaking the Silence” with global advocates: https://shows.acast.com/pregnantish/episodes/breaking-the-taboo-infertility-stories-from-around-the-world

Even as governments worldwide grapple with declining birth rates and the need for solutions, millions of people who hope to build their families continue to face significant barriers to care – including stigma, lack of awareness, financial obstacles, geographic limitations, and unequal access to fertility treatment.

“Infertility is a medical diagnosis, not a personal failure, yet too many people around the world continue to carry unnecessary shame while also facing issues accessing care,” said Andrea Syrtash, Founder of Pregnantish and creator of the World Fertility Project. “When (at least) 1 in 6 people experience infertility, this is not a ‘niche’ issue, it is a global health issue. Last year showed us the power of collective voices coming together to challenge stigma and spark conversation. This year, we’re expanding that movement and inviting even more people to share their stories, advocate for change, and help connect awareness to access.”

The campaign, first launched alongside the inaugural World Fertility Awards, invites participants to share videos and images of themselves tearing “Break the Taboo” signs in their native languages, a symbolic act that spread across social media, and to share why they are joining a growing global movement to increase awareness, reduce stigma, and support those struggling to conceive. The movement will continue throughout the year leading up to the second annual World Fertility Awards in New York City this December.

The 2026 campaign will kick off on June 17 with a synchronized global digital activation uniting voices across countries, cultures, and communities.

Returning campaign partner IVI RMA Global, one of the world’s largest and most respected reproductive medicine networks, will once again leverage its international network of physicians, researchers, and clinics to amplify the campaign across multiple regions.

Dr. Filipa Rafael, Consultant in Obstetrics & Gynaecology, Reproductive Medicine Specialist, IVI RMA Porto, shared, “Being connected to a global fertility movement (through the World Fertility Project) reminds me that, although we work in different countries and healthcare systems, our patients share the same hopes, fears, and challenges.”

Additional WFP ambassadors and supporters from around the world will participate in this year’s campaign and awards event to underscore the global nature of infertility and the need for greater awareness, education, and access to care.

Dr. Joseph Sgroi, Fertility Specialist at Melbourne IVF, shares: “The ability to learn from different systems, advocate collectively, and push for more equitable family-building options worldwide is incredibly powerful and needed.”

Dr. Brian Levine, Founding Partner of CCRM New York underscores that infertility doesn’t recognize borders – and neither should the solutions. “From New York to Mumbai, I’ve seen firsthand that while the science of family building is universal, access to care is not. By working together globally, we can reduce stigma, expand access, and help more people build the families they dream of.”

Participants are invited to join the movement by sharing their own “Break the Taboo” moment on social media using #BreakTheTaboo and #WorldFertilityProject and by taking the free pledge at https://www.worldfertilityproject.com/.

Learn more about World Fertility Awards: https://www.worldfertilityawards.com/.

Learn more about pregnantish: https://pregnantish.com/.

To get involved, find out more or for press inquiries: worldfertilityawards@pregnantish.com

MULTIMEDIA:

IMAGE Link for media: https://www.Send2Press.com/300dpi/26-0610-s2p-world-fertility-300dpi.webp

VIDEO (YouTube) – “Break the Taboo” Campaign: https://www.youtube.com/shorts/–RczjmRdkQ

NEWS SOURCE: Pregnantish

This press release was issued on behalf of the news source (Pregnantish), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/millions-dream-of-having-children-world-fertility-project-expands-global-break-the-taboo-campaign-to-address-stigma-and-barriers-to-care/

Montgomery County Neurological Center Urges Patients with Dizziness, Balance Disorders, Parkinson’s Disease, and Movement Conditions to Seek Specialized Physical Therapy

Neurology, Psychiatry and Balance Therapy Center Offers Neurologically-Informed Physical Therapy, Vestibular Rehabilitation, and Parkinson's Therapy Under One Roof in Montgomery County, Pennsylvania

BLUE BELL, Pa., June 9, 2026 (SEND2PRESS NEWSWIRE) — Millions of Americans living with dizziness, chronic balance problems, Parkinson’s disease, and neurological movement disorders struggle for months or even years before receiving the specialized care their conditions require. For many, the path forward begins, and often ends, with referrals to standard orthopedic physical therapy that was never designed to address the underlying neurological causes of their symptoms. Neurology, Psychiatry and Balance Therapy Center (NPBTC), a multi-specialty medical practice located at 725 Skippack Pike in Blue Bell, Pennsylvania, is raising awareness about the critical difference between general physical therapy and neurologically-informed rehabilitation, and urging patients and referring physicians throughout Montgomery County to understand when specialized neurological PT is the appropriate course of care.

Image caption: (L-R) Dr. James Barsky and Dr. Ian Haslam.

WHEN STANDARD PHYSICAL THERAPY IS NOT ENOUGH

Not all physical therapy is the same. Neurologically-informed physical therapy — also called neurological physical therapy or neuro PT — is a specialized approach designed specifically for patients whose movement, coordination, balance, or mobility challenges stem from conditions affecting the brain, inner ear, or peripheral nervous system.

While general physical therapy is well suited for post-surgical recovery, musculoskeletal injuries, and orthopedic rehabilitation, neurological PT is designed for a different category of patients, including those who:

Experience chronic dizziness including vertigo that has not resolved with standard treatment
Struggle with recurring falls or unexplained balance problems
Have been diagnosed with Parkinson’s disease and are managing progressive changes in gait, posture, or mobility
Are recovering from a stroke and working to restore motor function and independence
Live with functional neurological disorder (FND), a condition in which neurological symptoms occur without an identifiable structural cause
Are managing the physical impact of movement disorders such as tremor, rigidity, or dyskinesia
Have experienced a concussion and are still dealing with symptoms affecting coordination, gait, or vestibular function

NPBTC’s physical therapy program is built around this distinction. Every treatment plan begins with a thorough evaluation of how the nervous system is contributing to a patient’s movement and balance challenges — and progresses through targeted interventions designed to retrain the brain and body to work together more effectively.

VESTIBULAR THERAPY: AN UNDERUTILIZED RESOURCE FOR DIZZINESS AND BALANCE

One of the most underutilized forms of specialized rehabilitation is vestibular therapy, a category of neurological physical therapy focused on conditions affecting the inner ear and its connections to and within the brain. The vestibular system is responsible for the body’s sense of balance, spatial orientation, and eye-head coordination. When it is disrupted by injury, illness, or neurological disease, patients can experience debilitating dizziness, nausea, difficulty walking, and a persistent sense of instability.

Despite the availability of effective vestibular rehabilitation, many patients go undiagnosed or are treated with medication alone, which may or may not manage symptoms but does not always address the underlying dysfunction.

At NPBTC, vestibular therapy is available for patients with benign paroxysmal positional vertigo (BPPV), vestibular neuritis, labyrinthitis, vestibular migraine, Menière’s disease, post-concussion vestibular dysfunction, and other inner ear and central vestibular conditions.

PARKINSON’S DISEASE AND THE ROLE OF PHYSICAL THERAPY

For patients living with Parkinson’s disease, physical therapy is not simply a supportive tool — it is a medically recognized component of comprehensive Parkinson’s care. Research consistently supports the use of specialized exercise and rehabilitation interventions to help manage the motor symptoms associated with Parkinson’s, including rigidity, slowness of movement, balance instability, and changes in gait.

NPBTC offers dedicated Parkinson’s therapy that incorporates evidence-informed techniques designed to target the movement challenges specific to Parkinson’s disease. Treatment protocols include gait training with cueing strategies, balance and fall prevention training, exercises targeting amplitude of movement, and functional mobility work, all adapted to each patient’s current level of function and progression.

MOVEMENT DISORDER THERAPY AND FUNCTIONAL NEUROLOGICAL DISORDER

Beyond Parkinson’s disease, NPBTC’s physical therapy program also serves patients with a broader range of movement disorders and neurologically driven movement challenges. This includes individuals with functional neurological disorder (FND), a complex and often misunderstood condition in which neurological symptoms such as tremors, weakness, gait disturbances, and involuntary movements occur without a structural or degenerative cause.

Functional neurological disorder is increasingly recognized as a legitimate neurological diagnosis, yet patients with FND frequently encounter delays in diagnosis and difficulty finding clinicians trained in evidence-based treatment approaches. At NPBTC, the integrated model of care — bringing together neurology, psychiatry, and neurological physical therapy — is uniquely suited to the multidisciplinary management that FND often requires.

AN INTEGRATED MODEL THAT SETS NPBTC APART

What distinguishes NPBTC from standalone physical therapy practices is the depth of clinical collaboration available under one roof. The practice was co-founded in 2012 by James Barsky, PT, DPT and Sonya Knight, DO, FAPA, FAAN, who is triple board-certified in Psychiatry, Neurology, and Epilepsy. This founding partnership established an intentional integration between neurological medicine and rehabilitation that remains central to how care is delivered at NPBTC today.

Patients at NPBTC benefit from a clinical environment where the neurologist, psychiatrist, and physical therapist can communicate directly, share observations, and coordinate care, a model that is rare in standard outpatient settings. For complex neurological patients, this coordination is not a luxury. It is often what makes the difference between continued frustration and meaningful progress.

WHO SHOULD CONSIDER NEUROLOGICAL PHYSICAL THERAPY AT NPBTC

NPBTC encourages patients and referring providers to consider a consultation for neurological physical therapy if any of the following apply:

Persistent or recurring dizziness and vertigo that has not responded to prior treatment
Balance problems, frequent falls, or a fear of falling
A new or established diagnosis of Parkinson’s disease
Dizziness or imbalance related to stroke
Concussion symptoms affecting gait, balance, or vestibular function
A diagnosis of functional neurological disorder or suspected FND
Movement disorder symptoms including gait disturbances, rigidity, tremor, or coordination challenges

Patients do not always need a referral to begin care at NPBTC, though many are referred by neurologists, primary care physicians, ENT specialists, and other providers throughout the Philadelphia and Montgomery County region.

ABOUT NEUROLOGY, PSYCHIATRY AND BALANCE THERAPY CENTER (NPBTC)

Neurology, Psychiatry and Balance Therapy Center (NPBTC) is an integrated specialty medical practice located in Montgomery County at 725 Skippack Pike, Suite 130, Blue Bell, Pennsylvania 19422. The practice combines neurology, psychiatry, Deep TMS therapy, neurological physical therapy, vestibular therapy, and balance and gait rehabilitation under one coordinated care model. NPBTC was co-founded in 2012 by Sonya Knight, DO, FAPA, FAAN — triple board-certified in Psychiatry, Neurology, and Epilepsy — and James Barsky, DPT, a specialist in neurological physical therapy and vestibular rehabilitation. The practice serves patients throughout Montgomery County, Philadelphia, and surrounding communities.

To learn more or to schedule a consultation, visit https://www.npbtc.com/ or call (215) 591-0700.

LOGO link for media: https://www.npbtc.com/wp-content/uploads/2025/07/npbtc_logo-mobile-retina-1.png

NEWS SOURCE: Neurology, Psychiatry and Balance Therapy Center (NPBTC)

This press release was issued on behalf of the news source (Neurology, Psychiatry and Balance Therapy Center (NPBTC)), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/montgomery-county-neurological-center-urges-patients-with-dizziness-balance-disorders-parkinsons-disease-and-movement-conditions-to-seek-specialized-physical-therapy/

Family United Home Health Care Launches New Website to Improve Access to Care Services Across Missouri

New site helps families find Medicaid-covered services, eligibility information, and support resources in one place

ST. LOUIS, Mo., May 29, 2026 (SEND2PRESS NEWSWIRE) — Family United Home Health Care has launched a fully redesigned website to give Missouri families a clearer way to learn about Medicaid-covered health care services. Founded in 2013 by Kayundra Foster, who holds a master’s degree in Gerontology from Lindenwood University, the agency serves families across St. Louis, St. Peters, and Kansas City.

Image caption: Family United Home Health Care Website.

The new website was built to help families and caregivers find the information they need without confusion. It uses plain language, direct navigation, and a clear structure to organize service details. Unlike standard healthcare portals, this site was designed to be a functional tool for those who may be feeling overwhelmed by the complexities of the healthcare system.

Throughout the platform, visitors can explore the full range of services Family United Home Health Care offers through Medicaid, including:

In-Home Services: This section details personal care assistance, nurse visits, and help with daily activities for seniors and adults with disabilities, emphasizing the ability to remain independent in a home setting.
Consumer Directed Services (CDS): The section provides a step-by-step roadmap for this specific program, which allows participants to hire and manage their own caregivers, with the agency serving as the fiscal intermediary.
Adult Day Care: Visitors can find information regarding the agency’s community-based social and health programs, which provide structured activities and professional supervision for individuals during daytime hours.
Healthy Children and Youth (HCY) program: This specialized section focuses on medically necessary services for children and adolescents under age 21, detailing how families can access care for youth with disabilities or chronic health conditions.

To ensure families feel confident in their healthcare journey, each service page now features comprehensive insights into specific care plans. These sections explain entirely what is included in each service, who applies, and accepted payment methods. Each page is highly intuitive, clarifying every point of interest while specifying the exact process to follow and the steps the Family United Home Health Care team takes to initiate care.

Furthermore, the site clearly outlines which office locations facilitate each specific service, helping families determine exactly how these programs work and if they qualify for coverage before they begin the enrollment process.

Beyond care details, the site features a dedicated Events page, inviting the public to join in on agency activities and stay connected with the community. A specialized blog offers practical information and articles for everyone to learn more about care programs, tips, and more.

The platform differentiates itself by consolidating regulatory requirements, eligibility criteria, and procedural steps into a single user-centric interface. By integrating service-specific FAQs with a step-by-step roadmap for enrollment, the site functions as a comprehensive guide rather than a standard directory.

“Families dealing with a health crisis are already under enough pressure. They should not have to dig through a confusing website to find out whether their mother qualifies for care,” said Kayundra Foster, founder of Family United Home Health Care. “This site is built the way our agency works… around the family, not around us.”

To learn more about Family United Home Health Care services, visit: https://www.familyunitedhhc.com/.

ABOUT FAMILY UNITED HOME HEALTH CARE

Founded in 2013, Family United Home Health Care is a Missouri health care agency with offices in St. Louis, St. Peters, and Kansas City. The agency provides Medicaid-covered services — including in-home personal care, Consumer Directed Services, adult day programs, and the Healthy Children and Youth program — to seniors, adults with disabilities, and children across Missouri. Staff includes RNs, LPNs, CNAs, and trained personal care workers, each of whom undergoes background screening and ongoing training before working with clients.

Family United Home Health Care, 7390 Saint Charles Rock Road, St. Louis, Missouri 63133

NEWS SOURCE: Family United Home Health Care

This press release was issued on behalf of the news source (Family United Home Health Care), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/family-united-home-health-care-launches-new-website-to-improve-access-to-care-services-across-missouri/

MyBioSource Now Offers One of the Largest ELISA Kit Collections Available to Researchers Globally

Scientists worldwide can now order fresh, ready-to-use ELISA kits or request fully custom ones directly from MyBioSource, with global shipping and transparent pricing

SAN DIEGO, Calif., May 29, 2026 (SEND2PRESS NEWSWIRE) — Finding the right ELISA kit for a research project can take days, comparing suppliers, checking species compatibility, and waiting weeks for delivery. MyBioSource was founded to address these challenges. The San Diego-based company has put together a large, well-organized collection of ELISA kits that researchers can browse, compare, and order in one place. The company’s focus has always been simple: give scientists what they need, when they need it, without overcharging them.

Image caption: MyBioSource Now Offers One of the Largest ELISA Kit Collections Available to Researchers Globally.

KITS FOR ALMOST EVERY SPECIES AND SAMPLE TYPE

MyBioSource carries ELISA kits for a wide range of species, including human, mouse, rat, rabbit, bovine, canine, porcine, goat, sheep, monkey, chicken, guinea pig, and several others. This matters because not every lab works with the same organism, and having to switch suppliers for a different species wastes both time and money.

Their kits also work across different sample types, including serum, plasma, tissue homogenates, and cell culture supernatants. Researchers studying hormones, cytokines, growth factors, or infectious disease markers can find relevant kits listed with full technical datasheets, so there is no need to contact support to figure out basic specs before ordering.

FRESHLY PREPARED KITS AND CUSTOM ELISA SOLUTIONS

Most suppliers keep large batches of pre-assembled kits sitting in storage. MyBioSource does things differently — each kit is put together after the order comes in.

That means the product reaches a researcher’s lab fresh, with a longer shelf life, leading to more accurate and consistent results. For projects where no standard kit fits the bill, MyBioSource also builds custom ELISA Immunoassay Kits tailored to specific targets, species, or assay formats. Their custom kits are ready in two to three weeks and cost the same as a regular catalog order, which most suppliers do not offer.

A member of the MyBioSource team put it plainly: “We don’t want researchers wasting weeks trying to find something that works. If it’s not in the catalog, we’ll build it for you at no extra charge.”

STREAMLINED ORDERING AND GLOBAL AVAILABILITY

Researchers can always find up-to-date availability information in the MyBioSource catalog, which is updated daily. The company believes that cost shouldn’t be the reason a study is postponed, and that keeping prices competitive is essential.

Orders are accepted worldwide, and the site allows users to narrow their search by species, target, or sample type before purchasing. All product pages contain the information the researcher needs to make a sound decision, and there are no “back and forth” emails to go. If your lab encounters something in your experiments that is not listed in the catalog, the custom kit service is at your fingertips. MyBioSource makes it easy: spend less time shopping, more time in the lab.

“We built MyBioSource so that researchers don’t have to spend half their week just sourcing the right kit. Everything they need is already there — and if it’s not, we make it happen fast,” said a MyBioSource Spokesperson.

ABOUT MYBIOSOURCE

MyBioSource, Inc. began in 2006 when three scientists decided there had to be a better way to access high-quality lab reagents. Today, the company operates out of San Diego, California, and carries more than 2 million products — ELISA kits, antibodies, recombinant proteins, PCR kits, peptides, and more. Research teams at universities, biotech companies, and pharmaceutical firms around the world use MyBioSource because the products are reliable and the process is straightforward. Visit https://www.mybiosource.com/ to explore the full catalog.

CONTACT INFORMATION
Company Name: MyBioSource, Inc.
Email: sales@mybiosource.com
Website: https://www.mybiosource.com/
Address: San Diego, California, USA
Phone: +1 (855) 692 4676 (Toll-free within US & Canada)
+1 (858) 633 0165
Landline: +1 (858) 633 0166

Visit us on social media:

Facebook – https://www.facebook.com/mybiosourceinc

X – https://x.com/mybiosource

LinkedIn: https://www.linkedin.com/company/my-bio-source

MEDIA ONLY CONTACT:
Francesca Brown
+1(855)692 4676
francesca@mybiosource.com

MULTIMEDIA:
IMAGE link for media: https://www.Send2Press.com/300dpi/26-0529-s2p-MyBioSource-300dpi.webp

Image caption: MyBioSource Now Offers One of the Largest ELISA Kit Collections Available to Researchers Globally.

NEWS SOURCE: MyBioSource Inc.

This press release was issued on behalf of the news source (MyBioSource Inc.), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/mybiosource-now-offers-one-of-the-largest-elisa-kit-collections-available-to-researchers-globally/

Spodak Dental Group Recognized as a 2026 Sun Sentinel Top Workplace for the 10th Time

DELRAY BEACH, Fla., May 28, 2026 (SEND2PRESS NEWSWIRE) — Spodak Dental Group is proud to announce its recognition as a 2026 Sun Sentinel Top Workplace, marking the 10th time the organization has received the prestigious honor. The organization was the only dental office to be recognized in the Small Business category.

Image caption: Spodak Dental Group Recognized as a 2026 Sun Sentinel Top Workplace for the 10th Time.

The Top Workplaces awards are based entirely on feedback captured through a research-backed employee engagement survey, reflecting how team members experience the organization’s culture. The award recognizes companies that foster exceptional workplace culture, employee engagement, leadership, and organizational excellence.

For Spodak Dental Group, the recognition reflects five decades of commitment to building a practice where both patients and team members feel genuinely cared for.

Founded in 1976, Spodak Dental Group has become known for delivering a more elevated, personalized dental experience rooted in advanced care, thoughtful service, and long-term relationships.

“At Spodak Dental Group, we’ve always believed that great dentistry starts with great people,” said Erika Pusillo, CEO of Spodak Dental Group. “Receiving this recognition for the 10th time is incredibly meaningful because it reflects the culture our team has built together over many years. We are deeply committed to creating an environment where people feel supported, valued, challenged to grow, and inspired to deliver an exceptional patient experience every single day.”

The practice’s continued growth and recognition are rooted in a philosophy that has become central to the organization’s identity, “Dentistry, Done Differently.”

From minimally invasive treatment planning and advanced technology to hospitality-inspired patient care and ongoing team development, Spodak Dental Group continues to redefine what patients can expect from a dental experience.

The organization’s approach is built on the understanding that “when results matter, where you go matters.”

That philosophy has helped Spodak Dental Group earn the trust of generations of patients throughout South Florida while attracting top talent committed to excellence, compassion, and innovation.

Today, Spodak Dental Group remains focused on raising the standard for modern dentistry by creating an experience that feels more personal, more thoughtful, and more connected from the moment patients walk through the door.

For more information about Spodak Dental Group, career opportunities, or to schedule an appointment, please visit https://www.spodakdental.com/ or call/text (561) 303-2413.

About Spodak Dental Group:

The Spodak Dental Group, an Inc. 5000 honoree, has evolved to become South Florida’s premier, comprehensive dental facility, and comprises a world-class association of dental professionals poised to provide full-service dental care second-to-none in both scope and skill. The Spodak Dental Group team includes General and Restorative Dentists, Endodontists, Periodontists, Board Certified Oral and Maxillofacial Surgeons, Master Ceramic Artists and Anesthesiologists, as well as one of the nation’s only in-office dental labs.

NEWS SOURCE: Spodak Dental Group

This press release was issued on behalf of the news source (Spodak Dental Group), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/spodak-dental-group-recognized-as-a-2026-sun-sentinel-top-workplace-for-the-10th-time/

99 New Pharmaceutical Biotechnology and Healthcare Projects Drive Major Facility Investments in April 2026

JACKSONVILLE, Fla., May 27, 2026 (SEND2PRESS NEWSWIRE) — Industrial manufacturing activity remained strong in April 2026, led by sustained investment from the pharmaceutical, medical device, biotechnology, and healthcare sectors. Industrial SalesLeads research team identified 60 pharmaceutical, medical device, and biotechnology projects, along with 39 healthcare-related projects, signaling continued demand for facility modernization, expansion, and operational upgrades across the U.S. and Canada.

Image caption: Industrial SalesLeads, Inc.

The following are selected highlights on new Life Science industry news:

LIFE SCIENCES – BY PROJECT TYPE

Pharmaceutical, Medical Device, Biotechnology – 60

Healthcare – 39

LIFE SCIENCES – BY PROJECT LOCATION (TOP 5 STATES)

California – 12

Massachusetts – 11

Virginia – 10

Texas – 8

Michigan – 6

LIFE SCIENCES – BY PROJECT SCOPE/ACTIVITY

Renovation/Equipment Upgrade – 76

Relocation – 60

Expansion/Equipment Upgrade – 14

New Construction – 8

LIFE SCIENCES EQUIPMENT CATEGORIES IN DEMAND

In the month of April, identified life sciences project managers are procuring the following equipment:

80–89%: Lighting (85.9%), Networking/Security Equipment (82.8%)

40–49%: Building Renovation (47.5%)

10–19%: Compressed Air Systems, HVAC Equipment, Mechanical Construction, Fire Protection Equipment, Material Handling/Storage Equipment, Building Construction, Loading Dock Equipment, Conveyors, Heat Exchangers, Control Systems & Instrumentation

9%: Floor Coatings

7%: Air Emissions Control Equipment, Packaging Equipment, Tanks/Vessels – Stainless, Equipment Relocation

TOP 10 TRACKED LIFE SCIENCES PROJECTS

FLORIDA:

Healthcare provider is planning to invest $55 million for new construction of a 14,500sf medical and office in FL. They are currently seeking approval for the project.

GEORGIA:

Healthcare service provider has recently started a 317,000 sf expansion and renovation of their hospital in Cumming, GA. Completion is slated for late 2028.

OHIO:

Biotechnology company is planning to invest $18 million for the expansion and renovation of their warehouse, office, and laboratory facility in OH. They are currently seeking approval for the project. Construction is expected to start in Summer 2026.

MASSACHUSETTS:

Medical device manufacturer is planning for an expansion of their manufacturing facility in MA. They are currently seeking approval for the project.

MINNESOTA:

Pharmaceutical company is planning for the expansion and equipment upgrades on their processing facility in MN. They are currently seeking approval for the project.

MISSOURI:

Pharmaceutical company is planning for the construction of a processing facility in MO. They are currently seeking approval for the project.

NORTH CAROLINA:

Specialty healthcare service provider is planning to invest $2.7 million for the renovation of 10,000 sf of medical and office space in NC. They are currently seeking approval for the project.

NEW JERSEY:

Healthcare service provider is planning to invest $600 million for a 444,000 sf expansion of their hospital in NJ. They are currently seeking approval for the project.

NORTHERN CALIFORNIA:

Healthcare service provider is planning to invest $8 million for the renovation of a recently leased 39,000 sf of medical and office space at CA. They have recently received approval for the project.

NEW YORK:

Healthcare service provider is investing $21 million for the expansion and renovation of their medical and office facilities in NY. Completion is slated for late 2026.

LARGEST PLANNED PROJECT

The largest project is owned by Shine Technologies. Medical isotope technology company is constructing a processing facility in Janesville, WI. Completion is slated for Summer 2027.

ABOUT INDUSTRIAL SALESLEADS, INC.

Since 1959, Industrial SalesLeads, based in Jacksonville, FL is a leader in delivering industrial capital project intelligence and prospecting services for sales and marketing teams to ensure a predictable and scalable pipeline. Our Industrial Market Intelligence, IMI identifies timely insights on companies planning significant capital investments such as new construction, expansion, relocation, equipment modernization and plant closings in industrial facilities. The Outsourced Prospecting Services, an extension to your sales team, is designed to drive growth with qualified meetings and appointments for your internal sales team. Visit us at https://salesleadsinc.com/.

Each month, our team provides hundreds of industrial reports within a variety of industries.

Learn more at:

https://www.salesleadsinc.com/data-solutions/industrial-project-reports/

https://www.salesleadsinc.com/blog/

NEWS SOURCE: Industrial SalesLeads Inc

This press release was issued on behalf of the news source (Industrial SalesLeads Inc), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/99-new-pharmaceutical-biotechnology-and-healthcare-projects-drive-major-facility-investments-in-april-2026/

AAAbio Enhances Global Diagnostic Research Capabilities Through Strategic Local Distribution Networks

LA JOLLA, Calif., May 20, 2026 (SEND2PRESS NEWSWIRE) — In a move to significantly reduce lead times for critical diagnostic research components, AAAbio (AAA Biotech, LLC) has announced a major restructuring of its international logistics framework. By empowering a curated network of regional partners, the company is ensuring that its comprehensive suite of Elisa Kits and protein reagents is more accessible to the global scientific community than ever before.

Photo caption: AAAbio Enhances Global Diagnostic Research Capabilities Through Strategic Local Distribution Networks.

This strategic shift addresses one of the most persistent bottlenecks in biomedical research: the delay in acquiring high-sensitivity assay tools. With the rapid pace of modern clinical studies, the ability to receive validated Enzyme-Linked Immunosorbent Assay within days, rather than weeks, can be the deciding factor in the success of a time-sensitive project.

PRECISION AT THE LOCAL LEVEL

The core of this initiative is the decentralization of technical support and product availability. AAAbio recognizes that researchers in different geographic regions face unique regulatory and logistical challenges. By partnering with specialized distributors who understand local market dynamics, the company ensures that every laboratory, regardless of location, receives the same high standard of service and product integrity.

Each authorized distributor in the business’s network undergoes a rigorous selection process. These partners are not merely logistics providers; they are technical extensions of the brand, capable of providing on-the-ground support for complex assay protocols. This ensures that when a researcher utilizes ELISA from the company’s catalog, they have access to a local expert who can assist with optimization and troubleshooting.

BRIDGING THE GAP IN PROTEOMIC RESEARCH

Proteomics remains one of the most challenging frontiers in modern biology. The quantification of specific proteins within complex biological fluids requires tools of the highest specificity. AAAbiotech has spent years refining its manufacturing processes to produce ELISA products that offer industry-leading sensitivity and minimal cross-reactivity.

By making these tools available through a localized distribution model, the company is facilitating a more democratic landscape for scientific discovery. Smaller research institutions and biotech startups, which may have previously struggled with the complexities of international cold-chain shipping, can now source these high-end reagents through domestic channels.

The updated distributor portal on the business website serves as a centralized hub where researchers can identify their nearest authorized provider. This transparency is part of a broader commitment to customer-centric service, allowing scientists to focus on their data rather than their supply chain.

COMMITMENT TO REPRODUCIBILITY

The “reproducibility crisis” in life sciences is often linked to the use of poorly characterized reagents. AAAbiotech addresses this head-on by providing extensive validation data for every product in its inventory. Whether a researcher is looking for sandwich, competitive, or indirect formats, they can be confident that the kits have been tested against rigorous internal standards.

“Our goal is to remove the guesswork from the procurement process,” said the Director of Global Operations at AAAbiotech. “By strengthening our ties with local distributors, we are ensuring that the cold-chain requirements for our Elisa Kits are strictly maintained from our facility to the customer’s bench. This level of oversight is essential for maintaining the biological activity of the antibodies and proteins included in our kits.”

Learn more: https://www.aaabiotech.com/elisa-kits

FUTURE-PROOFING THE SUPPLY CHAIN

As the biotechnology sector continues to expand globally, particularly in regions like Southeast Asia and South America, the demand for reliable diagnostic tools is surging. AAAbio is actively seeking to expand its footprint in these emerging markets to support the next generation of global health breakthroughs.

ABOUT AAABIO

Headquartered in the biotech hub of La Jolla, California, AAAbio (AAA Biotech, LLC) is a premier manufacturer and supplier of high-quality life science reagents. The company’s portfolio includes an expansive range of antibodies, recombinant proteins, and Enzyme-Linked Immunosorbent Assay Kits designed to meet the exacting standards of the global research community. Through a combination of innovative manufacturing and a robust international distribution network, the company is dedicated to accelerating the pace of discovery in human health and disease.

For more information and queries:

Visit the company’s official website: https://www.aaabiotech.com/.

Tel: +1 (619) 604-9440
Fax: +1 (619) 604-9441
Toll Free: +1-800-604-9114
Email: info@aaabiotech.com
Tech Support: tech@aaabiotech.com

Visit us on social media:

Instagram – https://www.instagram.com/aaabiotech/

Facebook – https://www.facebook.com/people/AAA-Biotech/61578212701968/

X – https://x.com/aaabiotech1

Mailing Address: AAA Biotech, LLC, PO Box 1697, La Jolla, CA 92038

MEDIA ONLY CONTACT
Cynthia Lee
+1 619-604-9440
info@aaabiotech.com

MULTIMEDIA
Photo link for media: https://www.Send2Press.com/300dpi/26-0520-s2p-aaabio-300dpi.webp

Photo caption: AAAbio Enhances Global Diagnostic Research Capabilities Through Strategic Local Distribution Networks

***
UPDATED 5pm PDT to fix an inadvertent typographical error missed at time of publication.

NEWS SOURCE: AAA Biotech LLC (AAAbio)

This press release was issued on behalf of the news source (AAA Biotech LLC (AAAbio)), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/aaabio-enhances-global-diagnostic-research-capabilities-through-strategic-local-distribution-networks/

The Jackson Copeland Foundation Awarded $10,000 Grant from Duke Energy Foundation as Part of Commitment to Support Communities Across Florida

ST. PETERSBURG, Fla., May 19, 2026 (SEND2PRESS NEWSWIRE) — The Duke Energy Foundation announced it has awarded a $10,000 grant to The Jackson Copeland Foundation to help ensure families can afford essential living expenses following a blood cancer diagnosis. The grant is part of a larger commitment from Duke Energy Florida and its Foundation to support the vitality of the communities the company serves.

Image caption: The Jackson Copeland Foundation Awarded $10,000 Grant from Duke Energy Foundation.

“No one facing a blood cancer diagnosis should have to endure additional stress from the costs or logistics associated with treatment,” said Duke Energy Florida state president Melissa Seixas. “The Jackson Copeland Foundation is doing so much to help alleviate that burden for so many families here in our area. It’s an honor to support their important work.”

“A leukemia diagnosis shouldn’t mean a family loses their home while fighting for their life,” said Jeff Copeland, Founder & CEO of The Jackson Copeland Foundation. “This generous grant from the Duke Energy Foundation allows us to tackle the affordability crisis of blood cancer head-on, ensuring patients can secure temporary lodging and travel to life-saving treatments without facing financial ruin. They should be focused on the fight of their lives, not finances or foreclosure. This partnership ensures nobody fights this battle alone—Jackson would go, and so are we.”

There are only three National Cancer Institute-designated cancer centers in Florida, so hundreds of Florida blood cancer patients must travel to receive treatment each year. Patients receiving a life-saving bone marrow or stem cell transplant, in particular, must secure short-term lodging for up to 100 days during treatment and recovery, which creates a massive affordability crisis for most families.

The $10,000 grant will be used to fund “bridge grants” to low- and moderate-income families within Duke Energy’s Florida service footprint who are battling blood cancer. This grant directly addresses those staggering logistical and financial challenges. By covering critical non-medical living expenses—such as primary housing maintenance (rent/mortgage), temporary medical lodging, and transportation costs—the funds ensure the affordability of basic needs during the most disruptive months of a patient’s treatment. This rapid-response financial relief helps families avoid eviction, foreclosure, and bankruptcy, preserving their economic mobility so they can focus entirely on healing.

For more information on the Duke Energy Foundation and its initiatives, visit: https://foundation.duke-energy.com/

To learn more about The Jackson Copeland Foundation, apply for assistance, or join the mission, visit: https://jacksoncopeland.org/

NEWS SOURCE: The Jackson Copeland Foundation Inc.

This press release was issued on behalf of the news source (The Jackson Copeland Foundation Inc.), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/the-jackson-copeland-foundation-awarded-10000-grant-from-duke-energy-foundation-as-part-of-commitment-to-support-communities-across-florida/

New Residential Facility Opens in Clayton County, Bringing Much-Needed Addiction Treatment Access to South Atlanta

JONESBORO, Ga., May 15, 2026 (SEND2PRESS NEWSWIRE) — Samba Recovery Atlanta today announced it will officially open its Jonesboro facility to patients on May 18, 2026, expanding access to medically supervised detox and structured residential addiction treatment in Clayton County. Local leaders and community members previously gathered on April 13, 2026, for a ribbon-cutting ceremony and open house to mark the completion of the facility.

Image caption: Samba Recovery Atlanta leaders and a Clayton County commissioner cut the ribbon during the facility’s open house in Jonesboro, Georgia, celebrating expanded access to residential addiction treatment in South Atlanta area.

The opening arrives at a critical juncture for the south Atlanta region. According to recent public health data and Southern Regional Medical Center’s Community Health Needs Assessment, Clayton County faces unique vulnerabilities that compound substance use disorders:

OVERDOSE RATES: A statewide opioid continuum-of-care assessment placed Clayton County among the top 15 Georgia counties for total opioid overdose deaths in 2022.
AT-RISK POPULATIONS: The county currently ranks 47th among Georgia counties for nonmedical drug use and 46th for mental distress.
THE TREATMENT GAP: Compounded by above-average unemployment and high rates of underinsured residents, local options for the immersive residential treatment required for severe addiction have been very limited, often forcing families to travel long distances for immediate help.

“On behalf of Clayton County, I’m proud to welcome Samba Recovery Atlanta to our community,” said Clayton County Commissioner DeMont Davis. “The need for compassionate, high-quality treatment has never been greater, and this facility represents exactly the kind of resource Clayton County needs. Samba Recovery Atlanta will give individuals and families a place to find support, healing, and hope close to home.”

The project also represents a physical revitalization of the community. Samba Recovery transformed a formerly distressed, bankrupt property into a modern healing environment, an investment that has also created local jobs.

“Our mission is to transform lives through compassionate, evidence-based care, restoring hope, health, and connection for individuals and families impacted by addiction and mental health,” said Josh Bamberger, CEO of Samba Recovery. “We cherish the partnerships we have formed here. Let’s make today the start of something extraordinary as we work toward the common goal of lasting recovery.”

ABOUT SAMBA RECOVERY ATLANTA

Located in Jonesboro, Georgia, Samba Recovery Atlanta provides compassionate, evidence-based addiction treatment for the greater south Atlanta area. Part of the broader Samba Recovery network, the facility offers medically supervised detox, residential care, and ongoing recovery support designed to help clients rebuild their lives with dignity, structure, and hope.

For more information, visit: https://sambarecovery.com/ and https://sambarecovery.com/addiction-treatment-programs-georgia/inpatient-rehab-atlanta/

LOGO link for media: https://sambarecovery.com/wp-content/uploads/2025/09/logo-2-768×266.png

NEWS SOURCE: Samba Recovery

This press release was issued on behalf of the news source (Samba Recovery), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/new-residential-facility-opens-in-clayton-county-bringing-much-needed-addiction-treatment-access-to-south-atlanta/

Neurotech Reports Announces Thomas Stieglitz, Ph.D., as Keynote Speaker for the Second Annual Neurotech Leaders Forum imec

SAN FRANCISCO, Calif., May 14, 2026 (SEND2PRESS NEWSWIRE) — Neurotech Reports today announced that Thomas Stieglitz, Ph.D., a globally recognized expert in neural engineering and implantable neurotechnology, will keynote the Second Annual Neurotech Leaders Forum imec, taking place June 23-24, 2026, in Leuven, Belgium.

Photo caption: Thomas Stieglitz, Ph.D., will keynote the Second Annual Neurotech Leaders Forum imec.

The Neurotech Leaders Forum brings together senior executives, investors, researchers, clinicians, and technology developers working at the forefront of neurotechnology, bioelectronic medicine, and brain-computer interface innovation. The event serves as a platform for examining emerging technologies, commercialization trends, investment activity, and the evolving direction of the neurotech industry across Europe and internationally.

“Dr. Thomas Stieglitz represents the kind of visionary leadership that continues to drive the neurotechnology field forward,” said James Cavuoto, editor and publisher of Neurotech Reports. “His perspective on the convergence of engineering, neuroscience, and clinical application will provide tremendous value for attendees from across the neurotech ecosystem.”

“Advances in neural interfaces and bioelectronic medicine are creating entirely new possibilities for treating neurological disorders and restoring function,” said Dr. Stieglitz. “I am honored to participate in this year’s Neurotech Leaders Forum imec and contribute to the conversation about the future of neurotechnology.”

Dr. Stieglitz is widely recognized for his contributions to neural interface technologies and implantable systems aimed at restoring and modulating nervous system function. Throughout his career, he has combined academic leadership with entrepreneurial innovation, co-founding companies focused on neural implants and neuromodulation therapies. He has authored more than 200 scientific journal articles, contributed extensively to conference literature, and is named on dozens of patents spanning neurotechnology and biomedical engineering.

Launched in 2025, the Neurotech Leaders Forum imec has quickly become a key meeting point for neurotechnology executives, researchers, and investors from across Europe and North America. The 2026 Forum will bring together leaders in neurostimulation, brain-computer technologies, implantable devices, AI-enabled neurotechnology, and investment at imec, one of Europe’s leading research and innovation centers.

Additional information and registration details are available at: https://www.neurotechreports.com/pages/leadersforum-europe.html

More information about imec is available at: https://www.imec-int.com/

ABOUT NEUROTECH REPORTS

Neurotech Reports, part of Cambridge Innovation Institute, is a leading source of market research, industry analysis, and business news covering neurotechnology, neuromodulation, and bioelectronic medicine. Through its publications and executive conferences, the company provides insights into emerging technologies, commercial trends, and investment activity shaping the global neurotech industry. Learn more: https://www.neurotechreports.com/

MULTIMEDIA:

Photo link for media: https://www.Send2Press.com/300dpi/26-0514-s2p-stieglitz-300dpi.webp

Photo caption: Thomas Stieglitz, Ph.D., will keynote the Second Annual Neurotech Leaders Forum imec

LOGO: https://www.neurotechreports.com/images/nlf-imecFlag-horiz.png

NEWS SOURCE: Neurotech Reports

This press release was issued on behalf of the news source (Neurotech Reports), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/neurotech-reports-announces-thomas-stieglitz-ph-d-as-keynote-speaker-for-the-second-annual-neurotech-leaders-forum-imec/

Amba to Highlight Real-World Results in Webinar on Proactive, AI-Enabled Care

New case study shows sharp reductions in falls, hospitalizations, and missed care tasks at Tiffany Village and Kenny's Pond

NAPLES, Fla., May 14, 2026 (SEND2PRESS NEWSWIRE) — Amba, a leader in passive AI-powered care technology, will host a live webinar titled “From Staffing Crisis To Operational Advantage ” on May 20, 2026, focused on how senior living operators can move beyond reactive care and how working with better visibility and earlier insight improves operational efficiency.

Image caption: Tiffany Village will discuss how its care teams use Amba’s AI-powered passive care technology to reduce falls, hospitalizations, and missed care tasks across its senior living communities in the webinar “Staffing Crisis To Operational Advantage” on May 20, 2026.

The session, presented in partnership with Senior Housing News, will feature Kristen Parsons, President of Tiffany Village and Kenny’s Pond, alongside Amba Founder and CEO Stuart Hamilton. The two will walk through what changed over two years of using Amba, what that shift meant for care delivery, and how teams actually work day-to-day.

Amba uses passive, privacy-first sensors to track patterns in sleep, movement, and behavior, without cameras or audio. Over time, the platform builds a baseline for each resident and flags meaningful changes, helping teams decide when to step in and where to focus their attention.

The system is designed to work within existing environments, allowing communities to adopt it without overhauling infrastructure or workflows.

The webinar follows the release of a new case study based on results from the St. John’s, Newfoundland communities, where Amba has been used to provide care teams with clearer visibility into resident needs, enabling them to step in earlier before an infection or issue arises.

At Tiffany Village and Kenny’s Pond, care teams have seen fewer disruptions and more consistent care. Occupancy increased, and labor costs came down, while care teams reported feeling more confident in how they prioritize their day, in data analyzed from 2023 to 2025:

Result highlights at Tiffany Village and Kenney’s Pond include:

89% reduction in falls
78% reduction in medication issues
97% reduction in hospitalizations

“Amba is very easy to fall in love with,” said Parsons. “Once your team sees the benefit and starts using it every day, it becomes part of how you deliver care.”

These outcomes were achieved without adding staff, challenging the assumption that better outcomes require more staffing.

“Most communities aren’t short on effort; they’re short on visibility,” said Amba’s Hamilton. “When teams can see what’s changing in real time, they don’t have to wait for something to go wrong. They can step in earlier, with more confidence, and focus their time where it actually matters.”

During the webinar, attendees will hear directly from Parsons about what it took to implement the system, where things started to change, and how their approach to care has evolved over time.

Topics include:

How to increase caregiver capacity without adding payroll
Why many systems keep communities stuck in reactive workflows
What proactive care actually looks like in practice
What two years of real data reveal about operations

Webinar Details: The webinar is scheduled for Wednesday, May 20, 2026, at 12 p.m. Eastern. To register or download the case study, visit: https://event.on24.com/wcc/r/5323094/16843E5E12924BD0B946E1C5C11C26D9?partnerref=amba

ABOUT AMBA

Amba is a technology platform designed to support a more proactive approach to care in senior living environments. Using a network of passive, discreet sensors, it continuously monitors patterns related to sleep, movement, and in-room activity without cameras or audio. The platform builds an understanding of each resident’s baseline and surfaces meaningful changes, helping care teams act earlier and focus their attention where it matters most. Designed to work within existing environments, Amba can be adopted without major infrastructure changes, making it easier for communities to improve care consistency and reduce guesswork. Learn more at: https://amba.co/

MULTIMEDIA:

IMAGE link for media: https://www.Send2Press.com/300dpi/26-0514-s2p-amba-300dpi.webp

NEWS SOURCE: Amba

This press release was issued on behalf of the news source (Amba), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/amba-to-highlight-real-world-results-in-webinar-on-proactive-ai-enabled-care/

AgingIN Opens Registration for Longevity Pre-Summit and 2026 Conference ‘Peak Purpose: Redefining How We Live and Age’

BALTIMORE, Md., May 7, 2026 (SEND2PRESS NEWSWIRE) — AgingIN, a national leader advancing innovation in eldercare, has opened registration for its highly anticipated annual conference, “Peak Purpose: Redefining How We Live and Age.” The event will explore the impact of how people-first living improves care and strengthens culture while helping organizations perform better.

Image caption: AgingIN, a national leader advancing innovation in eldercare.

Designed for frontline care team members to executives across independent living, assisted living, memory care, skilled nursing, and PACE programs, the AgingIN 2026 conference includes practical learning and actionable strategies that can be applied immediately.

“Many of us got started in aging services because we care. Learning more person-centered strategies will help us lead more clearly, and be more aligned and better equipped to put people, not systems, at the center of our care,” said Susan Ryan, AgingIN CEO.

This year’s pre-conference experience, “The Longevity Summit: Living Longer, Living Better,” is headlined by keynote speaker Dr. Shelly Chadha of the World Health Organization, who will spotlight advancements and collaborative solutions to close the gap between healthspan and lifespan.

Throughout the summit, thought leaders, practitioners, and researchers will explore transformative approaches to well-being, integrated care models, and the role of innovation in extending quality of life for aging populations.

AgingIN encourages members of the media to register for complimentary access to key sessions, speakers, and insights shaping the future of aging services.

Registration is now open. To learn more and secure your spot, visit: https://aginginnovation.org/events/annual-conference/.

Additional details, including the conference microsite and full agenda, will be released soon.

ABOUT AGINGIN

LOGO link for media: https://www.send2press.com/300dpi/25-0812-s2p-agingin-300dpi.jpg

NEWS SOURCE: AgingIN

To view the original story, visit: https://www.send2press.com/wire/agingin-opens-registration-for-longevity-pre-summit-and-2026-conference-peak-purpose-redefining-how-we-live-and-age/

Maryland RN Launches Platform to Close the Home Care Affordability Gap – Without Sacrificing the Standard Families Demand

CareopsHQ's White Glove Senior Care Program offers vetted caregivers and nurse advocates at a fraction of agency costs

FREDERICK, Md., May 1, 2026 (SEND2PRESS NEWSWIRE) — CareopsHQ today officially launches its White Glove Senior Care Program, giving Maryland families a vetted, affordable alternative to traditional home care agencies — and giving hospital discharge planners, social workers, and geriatric care teams a first-of-its-kind referral option they can stand behind.

Image caption: CareopsHQ — White Glove Senior Care Program.

Founded by Magna Johnston-Bucknor, a registered nurse with more than 25 years of clinical experience across multiple specialties and a currently a home care agency owner, CareopsHQ was built after Johnston-Bucknor witnessed firsthand what happens when families cannot afford agency care: they turn to unvetted caregivers with no training, no oversight, and no support — and both the family and the caregiver are left to fail alone.

THE COST CASE AT A GLANCE

For the majority of Maryland families, traditional home care costs are simply out of reach:

$5,000 or more per month — over $60,000 a year — for 40 hours of weekly agency care
$20,000 or more in estimated annual savings for families who enroll in the White Glove program
$500 one-time enrollment fee to access the full White Glove system

Families get the same caliber of vetted, trained caregiver support they would expect from a traditional agency — at a fraction of the cost.

“The problem was never just cost. It was that families who couldn’t afford agencies had no vetted alternative — and caregivers were failing not from lack of effort, but from lack of training in the human side of the job. I built CareopsHQ to close both gaps at once,” said Magna Johnston-Bucknor, Founder, CareopsHQ, Registered Nurse and Home Care Agency Owner.

WHAT MAKES THE WHITE GLOVE PROGRAM DIFFERENT

CareopsHQ’s White Glove Senior Care Program is purpose-built for healthcare professionals who need a trustworthy, affordable alternative to traditional agency referrals. Every placement goes through a rigorous process designed to protect families and support caregivers:

Agency-vetted caregivers background-checked and screened for behavioral and cultural fit before any placement is made
Soft-skills training covering conflict de-escalation, communication, dignity in care, and family emotional support
A dedicated nurse advocate in every case providing clinical oversight and ongoing accountability
Payroll compliance tools supporting families in their role as household employers
A performance accountability system ensuring care standards are maintained throughout the engagement

This is not a matching platform or a directory. CareopsHQ operates to agency standards, applying the same screening rigor families would expect from a licensed agency — at a fraction of the cost. The nurse advocate role is what Johnston-Bucknor identified as the missing piece in most private caregiver arrangements: a licensed professional in the family’s corner, ensuring the relationship stays on track and care never becomes a liability for the clinician who made the referral.

FOR DISCHARGE PLANNERS AND SOCIAL WORKERS

Making a referral to CareopsHQ is straightforward. Healthcare professionals can direct families to https://careopshq.com/, where a one-time $500 enrollment connects them immediately to the full White Glove system. For clinicians managing complex discharge situations where traditional agency placement is not financially viable, CareopsHQ fills a gap that has historically had no good solution — a vetted, structured option rather than leaving families to navigate private care on their own.

“Affordable should never mean second-rate. Every senior deserves care that upholds their dignity — and every family deserves a system that doesn’t collapse when something goes wrong,” said Magna Johnston-Bucknor, Founder, CareopsHQ.

CareopsHQ’s White Glove Senior Care Program is currently available across Maryland. To refer a family or schedule a partner briefing, visit: https://careopshq.com/.

ABOUT CAREOPSHQ

CareopsHQ is a Maryland-based senior care platform founded by Magna Johnston-Bucknor, a registered nurse with more than 25 years of clinical experience across multiple specialties and an active licensed home care agency owner. Johnston-Bucknor built CareopsHQ after identifying a critical gap in the Maryland senior care market: families who could not afford traditional agency rates had no vetted, structured alternative. The White Glove Senior Care Program provides agency-vetted caregiver placement, nurse advocate support, soft-skills training, and payroll compliance tools at a fraction of traditional agency costs. CareopsHQ is not a licensed home care agency. The platform supports families in their role as household employers, ensuring legal compliance and care accountability throughout the engagement.

MEDIA AND REFERRAL PARTNER CONTACT:
Magna Johnston-Bucknor, Founder
CareopsHQ — White Glove Senior Care Program
Frederick, Md.
Web: https://careopshq.com/
Media inquiries: [info@careopsHQ.com]
Referral partnerships: [info@careopsHQ.com]
Phone: [240-750-6617]

NEWS SOURCE: CareopsHQ

This press release was issued on behalf of the news source (CareopsHQ), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/maryland-rn-launches-platform-to-close-the-home-care-affordability-gap-without-sacrificing-the-standard-families-demand/

Legacy Dental: Your Trusted Partner for Dental Emergencies

SALT LAKE CITY, Utah, April 22, 2026 (SEND2PRESS NEWSWIRE) — Legacy Dental, a leading dental practice dedicated to providing exceptional care, understands that dental emergencies can happen at any time. With a commitment to patient comfort and advanced treatment options, Legacy Dental is uniquely positioned to handle a wide range of dental emergencies with expertise and compassion.

Image caption: Meet the Team at Legacy Dental.

Highly Trained Dental Team

At Legacy Dental, our success in managing dental emergencies begins with our highly trained dental team. Each member of our staff undergoes rigorous training and continuing education to stay updated on the latest dental practices and technologies. Our dentists and hygienists are not only skilled but also genuinely care about each patient’s well-being. This combination of expertise and empathy ensures that patients receive the best possible care during stressful situations.

State-of-the-Art Technology and Treatments

Legacy Dental prides itself on utilizing the latest technology and treatment methods to address dental emergencies effectively. Our practice is equipped with advanced tools, including digital X-rays, 3D imaging, and AI assisted diagnostics, which allow us to quickly assess the situation and develop an appropriate treatment plan. Whether it’s a severe toothache, a broken tooth, or an oral injury, our cutting-edge technology enables us to provide accurate diagnoses and immediate solutions.

All Services Under One Roof

One of the key advantages of choosing Legacy Dental for dental emergencies is that we offer all services under one roof. Unlike many practices that refer patients to specialists, we have a comprehensive range of services available in-house. From root canals and extractions to restorative treatments and cosmetic dentistry, our patients can receive all necessary care without the hassle of multiple appointments or referrals. This not only saves time but also ensures continuity of care, which is crucial during emergencies.

Comprehensive Sedation Options

Understanding that dental emergencies can be anxiety-inducing, Legacy Dental offers all three forms of sedation: nitrous oxide, oral sedation, and IV sedation. Our goal is to make every patient feel comfortable and relaxed during their treatment. Whether a patient is experiencing mild anxiety or requires extensive procedures, our sedation options allow us to tailor the experience to individual needs, ensuring a calm and stress-free environment.

Friendly, Warm, and Caring Team

At Legacy Dental, we believe that a friendly and compassionate team can make all the difference during a dental emergency. Our staff is dedicated to providing a warm and welcoming atmosphere. We take the time to listen to our patients, address their concerns, and guide them through their treatment options. Our focus on patient care extends to providing emotional support, which is often just as important as the clinical treatment itself.

Extended Hours of Operation

Dental emergencies don’t always occur during regular office hours. That’s why Legacy Dental offers extended hours of operation, including evenings and weekends. We are committed to being available when our patients need us most. Whether it’s a late-night toothache or an injury over the weekend, our team is ready to assist, ensuring that patients receive timely care when they need it.

In-Network with Most Insurance Plans

Affordability is a priority for many of our patients, especially during emergencies. Legacy Dental is in-network with most insurance plans, making it easier for patients to access the care they need without financial stress. We work diligently to maximize insurance benefits and minimize out-of-pocket costs.

Flexible Financing Options

In addition to being in-network with many insurance providers, Legacy Dental offers in-house and third-party financing options to accommodate different budgets. We understand that dental emergencies can be unexpected and financially burdensome, so we strive to provide flexible payment plans that allow patients to receive the necessary treatments without delay.

Conclusion

When dental emergencies arise, patients can trust Legacy Dental to provide exceptional care, advanced technology, and a warm, supportive environment. Our highly trained team, comprehensive in-house services, extensive sedation options, and commitment to patient well-being make us the ideal choice for handling dental emergencies.

For more information or to schedule an appointment, visit us at https://legacydental.com/ or call us at (801) 278-4223.

About Legacy Dental

Legacy Dental is a leading dental practice located in Salt Lake City, dedicated to providing high-quality dental care in a comfortable and welcoming environment. With a focus on innovative treatments and patient-centered care, Legacy Dental strives to enhance the smiles and health of its community. The practice offers a wide range of services, from routine dental check-ups to advanced restorative and cosmetic procedures, ensuring that every patient receives the care they deserve.

For more information about Legacy Dental and its services, visit https://legacydental.com/.

Hours of operation: Monday through Thursday from 8 a.m. to 8 p.m.; Friday from 8 a.m. to 5 p.m.; and Saturday from 8 a.m. to 2 p.m.

NEWS SOURCE: Legacy Dental

This press release was issued on behalf of the news source (Legacy Dental), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/legacy-dental-your-trusted-partner-for-dental-emergencies/

Caregiving Is Personal for Many Simpson Team Members

During Care Workers Recognition Month, Simpson Shares How Personal Caregiving Shapes Care from Frontline to Executive Leadership

WEST GROVE, Pa., April 21, 2026 (SEND2PRESS NEWSWIRE) — In recognition of Care Workers Recognition Month in April, Simpson, a family of communities in Pennsylvania, is sharing how the personal caregiving experiences of its team members, from frontline staff to executive leadership, influence the care they bring to their roles every day.

Image caption: Jennifer Ragonese, RN, offers education and support at the Jenner’s Pond and Simpson Meadows senior communities while caring for her mother, Catherine Ahearn.

Across the country, more than 60 million Americans serve as family caregivers, many while balancing full-time jobs. These experiences often form the foundation of careers in senior living and healthcare, where empathy and hands-on knowledge shape how care is delivered.

Across Simpson communities, which offer independent living, assisted living, memory support, short-term rehabilitation, and skilled nursing, caregiving extends beyond the workplace. Many team members support loved ones at home while also providing compassionate care to residents each day. These shared experiences bring a deeper level of understanding and connection to the care they provide.

These experiences reflect a broader shift in the care workforce. As demand for senior living and long-term care continues to grow, many professionals are entering the field with personal caregiving experience that they apply to their work.

For Jennifer Ragonese, RN, at the Simpson Resource Center, who offers education and support at the Jenner’s Pond and Simpson Meadows senior communities, caregiving has been a lifelong influence. She supported her mother, Cathy, through vascular dementia, navigating a rapid progression of the disease that led from home care to long-term care placement.

“Being able to relate to those you care for is a superpower,” Ragonese said. “I learned early on to meet people where they are, to create a safe and trusting space, and let them guide the way.”

That perspective now shapes how she connects not only with residents but also with their families, helping to build trust and foster open communication during some of life’s most difficult transitions.

At Simpson Meadows in Downingtown, Penn., Memory Care Director Yalonda Pinder brings a similarly personal lens to her work. She helps care for her 84-year-old grandmother with dementia while also supporting a cousin who lives in the community’s memory care neighborhood.

With more than two decades of caregiving experience, Pinder draws on both her professional and personal roles to guide families with empathy.

She often reminds families that their loved ones cannot control their behaviors. Drawing on her personal caregiving experience, she emphasizes the importance of patience.

This perspective also extends to the care for her grandmother. When her grandmother was getting up at night, Pinder reminded her mom that her grandmother, who was also a CNA, worked the night shift, and she’s still on that schedule. This insight helped the family better understand and adjust their approach.

Simpson President and CEO Dr. Carol McKinley emphasizes that caregiving is both deeply personal and widely shared. Through initiatives such as Care for the Caregiver, a joint program with Jenner’s Pond and the University of Delaware, Simpson continues to focus on the well-being of those who care for others.

“Caregiving often involves a mix of love, responsibility, and emotional strain, and we understand from a personal and professional level that many caregivers feel overwhelmed or isolated without support,” says McKinley. As a caregiver for her grandmother, father and now her mother, McKinley brings a personal perspective to her work.

Under her leadership, Simpson continues to invest in programs that provide caregivers with resources, guidance, and a sense of community, reinforcing that no one should navigate caregiving alone.

Care team members remind others to show their appreciation with a simple “Thank you,” to listen to them when they need to vent their feelings, and share what they are going through with a handwritten note or conversation that acknowledges their efforts, says Ragonese.

“Many on our team are caring for family members when we go home,” says Pinder. “We care deeply about those we care for. At Simpson Meadows, we are family-oriented and treat the residents like our family.”

As part of Care Workers Recognition Month, and year-round, Simpson recognizes the many individuals across all roles who make quality care possible.

“Caregiving is hard and important, but we still need to take time for ourselves. We often put our needs aside, but burnout is real. Taking care of our mental and physical health helps us keep showing up for the people we care about,” says Ragonese.

ABOUT SIMPSON

Since 1865, Simpson has met the changing needs and desires of Philadelphia area seniors from diverse backgrounds as a not-for-profit family of services consisting of two Continuing Care Retirement Communities, or CCRCs: Simpson Meadows and Jenner’s Pond; three affordable senior living communities: Simpson Gardens I, Simpson Gardens II, and Simpson Midtown, as well as Simpson HomeCare and Simpson Rehabilitation. The organization is dedicated to providing elders from diverse backgrounds with more amenities, better services, improved care, and a higher quality of life in beautiful, dignified, and spiritual settings. For more information, visit: https://www.simpsonsenior.org/

Press Page: https://www.simpsonsenior.org/about/press/

NEWS SOURCE: Simpson

To view the original story, visit: https://www.send2press.com/wire/caregiving-is-personal-for-many-simpson-team-members/

Caregiving Is Personal for Many Simpson Team Members

During Care Workers Recognition Month, Simpson Shares How Personal Caregiving Shapes Care from Frontline to Executive Leadership

Image caption: Jennifer Ragonese, RN, offers education and support at the Jenner’s Pond and Simpson Meadows senior communities while caring for her mother, Catherine Ahearn.

With more than two decades of caregiving experience, Pinder draws on both her professional and personal roles to guide families with empathy.

She often reminds families that their loved ones cannot control their behaviors. Drawing on her personal caregiving experience, she emphasizes the importance of patience.

Under her leadership, Simpson continues to invest in programs that provide caregivers with resources, guidance, and a sense of community, reinforcing that no one should navigate caregiving alone.

As part of Care Workers Recognition Month, and year-round, Simpson recognizes the many individuals across all roles who make quality care possible.

ABOUT SIMPSON

Press Page: https://www.simpsonsenior.org/about/press/

NEWS SOURCE: Simpson

To view the original story, visit: https://www.send2press.com/wire/caregiving-is-personal-for-many-simpson-team-members/

RespondWell Launches First Telemedicine Platform Built Exclusively for First Responders

Built by active duty first responders, RespondWell gives firefighters, police, EMS, and dispatchers nationwide fast access to licensed health solutions

DENVER, Colo., April 20, 2026 (SEND2PRESS NEWSWIRE) — RespondWell™, a direct-to-consumer telehealth platform designed exclusively for the tactical athlete, officially launched today. The LegitScript-certified platform connects first responders nationwide with licensed healthcare providers and FDA-registered pharmacies to deliver specialized prescription wellness treatments directly to their doors.

Image caption: RespondWell: Built for those who run towards danger.

The platform was built around a simple premise: first responders deserve healthcare that works on their schedule, not the other way around. RespondWell was co-founded by active first responders Joe and Jake, who built the platform after experiencing firsthand the barriers their community faces when accessing consistent, effective healthcare.

“I spent years on the job watching guys push through low T, weight gain, and burnout because the healthcare system made it too hard to get help,” said Joe, co-founder of RespondWell. “We built this because we lived it – and we’re still living it.”

“Six years into the GLP-1 era and guys are still walking out of their doctor’s office with a lecture about eating better and hitting the gym,” said Jake, co-founder of RespondWell. “The access problem didn’t go away. When your life – and the lives of the people counting on you – depend on you being fit for duty, you shouldn’t have to fight your own healthcare system to get there.”

“At RespondWell, performance is a normal conversation,” said Joe. “First responders aren’t cheating and they’re not taking shortcuts. The job destroys your hormones, wrecks your sleep, and grinds down your body. Real, documented physiological consequences of this career – and then the system treats you like you’re asking for something suspicious when you want to fix it. That stops here.”

HOW IT WORKS

Patients complete a brief online health assessment – typically in under 10 minutes. A licensed provider from RespondWell’s partner Medical Group then conducts a clinical evaluation asynchronously where permitted – meaning the provider reviews, assesses, and responds on their end without the patient needing to be present at a specific time. It’s a real medical visit, built around the patient’s schedule instead of the other way around.

Certain treatments, including testosterone replacement therapy, require a video consultation with a licensed provider. The entire process happens online, with no waiting rooms, no in-person visits, and no unnecessary delays. If clinically appropriate, a prescription ships directly from an FDA-registered partner pharmacy. Average turnaround is four hours.

TREATMENT CATEGORIES CURRENTLY AVAILABLE ON THE PLATFORM INCLUDE:

GLP-1 weight management – clinically supervised weight loss programs utilizing customized GLP-1 medications
Testosterone replacement therapy (TRT) – for men experiencing low testosterone, a condition disproportionately affecting those in high-stress occupations
Sexual health – including tadalafil and TriMix for erectile dysfunction, delivered discreetly.
Hormone optimization – enclomiphene and NAD+ for performance and longevity support
Growth hormone support – sermorelin to support recovery, sleep quality, and long-term physical performance in those whose bodies are under sustained occupational stress

All treatments are prescribed by licensed providers and dispensed by FDA-registered pharmacies.

BUILT FOR THE JOB

Research consistently shows that first responders – including the dispatchers who coordinate every call but rarely get counted – face elevated rates of metabolic dysfunction, hormonal imbalance, and weight-related health conditions, driven by irregular sleep, chronic occupational stress, and limited access to consistent care. Despite these known risks, most telehealth platforms are designed for a general population with standard schedules and predictable routines.

RespondWell was purpose-built for the tactical athlete: fast intake, real providers, pharmacy-grade medications, and ongoing follow-up care that doesn’t require the patient to rearrange their shift. The platform is currently available to first responders in all 50 states.

GETTING STARTED

First responders can complete their online health assessment at https://respondwell.health.

ABOUT RESPONDWELL

RespondWell, LLC is a Denver, Colorado-based telehealth technology platform serving first responders nationwide. The platform connects patients with licensed providers from its partner Medical Group and FDA-registered compounding pharmacies for prescription wellness treatments. All clinical decisions are made by independent licensed healthcare providers.

Peak Performance. Mission Ready.

IMPORTANT DISCLAIMERS: The information contained in this press release is for informational purposes only and does not constitute medical advice. Nothing in this release should be construed as a diagnosis, treatment recommendation, or substitute for consultation with a qualified healthcare provider. All treatments referenced are available by prescription only, following an independent clinical evaluation by a licensed provider. Individual results vary. These statements have not been evaluated by the Food and Drug Administration. The treatments and products referenced are not intended to diagnose, treat, cure, or prevent any disease.

MULTIMEDIA:

VIDEO (YouTube): https://www.youtube.com/watch?v=XVh1zoTqsqE

LOGO link for media: https://respondwell.health/assets/respondwell_press_logo.png

NEWS SOURCE: RespondWell LLC

This press release was issued on behalf of the news source (RespondWell LLC), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/respondwell-launches-first-telemedicine-platform-built-exclusively-for-first-responders/

ViewTech Borescopes to Demonstrate Clean-In-Place Visual Inspection Solutions at INTERPHEX 2026

NEW YORK, N.Y., April 20, 2026 (SEND2PRESS NEWSWIRE) — ViewTech Borescopes, a leading provider of remote visual inspection (RVI) equipment, is returning to exhibit at INTERPHEX, the premier global pharma and biotechnology event. Attendees are invited to visit the ViewTech Borescopes booth 1943 to experience live demonstrations of its industry-leading video borescope technology designed to improve inspection efficiency, safety, and compliance in critical pharmaceutical manufacturing environments.

Image caption: ViewTech Borescopes showcases its advanced video borescope technology for pharmaceutical and biotechnology applications at INTERPHEX (Booth 1943), highlighting solutions designed to improve inspection efficiency, safety, and compliance in critical manufacturing environments.

At INTERPHEX, ViewTech will showcase its latest lineup of high-resolution video borescopes engineered for precise, non-destructive inspection in pharmaceutical processing equipment, cleanrooms, and hard-to-reach areas. These tools enable manufacturers to identify potential issues without disassembly, reducing downtime and supporting strict regulatory standards.

“INTERPHEX provides an excellent opportunity to connect with pharmaceutical professionals focused on quality, and safety,” said Chris Courtright, Sales Consultant at ViewTech Borescopes. “Our Ultraviolet video borescope solutions are designed to evaluate their clean-in-place (CIP) processes and riboflavin coverage testing, and we’re excited to demonstrate how our technology delivers measurable value.”

Read more about INTERPHEX 2026: https://www.viewtech.com/about-us/tradeshows/interphex-2026/

TRY BEFORE YOU BUY

In addition to live demonstrations during INTERPHEX 2026, ViewTech offers an exclusive No-Cost, No-Obligation Demo Program. This program allows end-users the opportunity to evaluate a ViewTech video borescope at their own facility on their own equipment, ensuring the technology meets their specific inspection requirements before any financial commitment.

VJ-3 AND VJ-4 VIDEO BORESCOPE

The VJ-3 and VJ-4 mechanical articulating video borescopes are nondestructive visual testing instruments used for the remote visual inspection of machinery, equipment, and components. With diameters as small as 0.85mm, the VJ-3 and VJ-4 facilitate the visual recording and photo documentation of an inspection and components in areas that are otherwise inaccessible or require significant effort and expense to access directly. The VJ-3 and VJ-4 video borescopes consist of two modules integrated into one system: an insertion tube with distally mounted camera/LEDs and the base unit with control panel, LCD monitor, power source, and all necessary circuitry.

ABOUT VIEWTECH BORESCOPES

ViewTech Borescopes, founded as RF System Lab in 2008, is North America’s top seller of video borescopes. Their first product, the VJ borescope, set a new standard for portability, ergonomics, and ease-of-use, with its industry-first mechanical, joystick-controlled articulation.

Learn more: https://www.viewtech.com/

MULTIMEDIA

Image link for media: https://www.Send2Press.com/300dpi/26-0420-s2p-vtech-300dpi.webp

Logo link: https://www.viewtech.com/wp-content/uploads/view-tech-logo-h-650.png

NEWS SOURCE: ViewTech Borescopes

This press release was issued on behalf of the news source (ViewTech Borescopes), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/viewtech-borescopes-to-demonstrate-clean-in-place-visual-inspection-solutions-at-interphex-2026/

Kevin Sorbo to Star in ‘The Gathering Place,’ Film Inspired by Delray Beach Senior Center Helping Seniors Overcome Isolation

South Florida Medical and Behavioral Health Institute's senior center-shaped by the real-life impact of Randy Kirshbaum and Vicky Samuelson-inspires upcoming JC Films production

DELRAY BEACH, Fla., April 7, 2026 (SEND2PRESS NEWSWIRE) — Acclaimed actor Kevin Sorbo is set to participate in the upcoming feature film “The Gathering Place,” a new JC Films production inspired by a Delray Beach senior center operated by South Florida Medical and Behavioral Health Institute, a 501(c)(3) nonprofit organization.

Image caption: South Florida Medical and Behavioral Health Institute.

The film is inspired by the real-life impact of Randy Kirshbaum and Vicky Samuelson in Delray Beach, whose work has helped transform the lives of seniors facing grief, isolation, and loss.

Filming for “The Gathering Place” is scheduled to begin in January 2027 in Delray Beach, Florida, bringing national attention to a growing issue: senior isolation and the urgent need for community-based solutions.

At the South Florida Medical and Behavioral Health Institute senior center located at Delray Medical & Dental, many seniors arrive after experiencing devastating life events—including the loss of a spouse or even a child. These hardships often leave individuals isolated, disconnected, and struggling with a loss of purpose.

What makes this story especially compelling—and highly relevant today—is the measurable transformation happening within this Delray Beach senior center.

Through structured weekly programming, wellness activities, and a strong sense of community, the South Florida Medical and Behavioral Health Institute is helping seniors rebuild their lives. Individuals who once felt alone are now forming meaningful friendships, improving their physical and emotional health, and rediscovering a renewed zest for life.

“This is not just a story for the screen—it’s something we witness every single day here in Delray Beach,” said Randy Kirshbaum, Chief Operating Officer of South Florida Medical and Behavioral Health Institute. “We serve seniors who come to us after experiencing unimaginable loss. They arrive isolated and grieving, and over time, they begin to smile again, to connect, and to truly live again.”

Kirshbaum emphasized that the Delray Beach senior center has become a critical lifeline.

“This center gives people back their sense of belonging. It gives them friendships, structure, and hope. That transformation is real – and it’s exactly what ‘The Gathering Place’ movie brings to life.”

“The Gathering Place” follows a diverse group of seniors who come together to save their beloved senior center from closing—a storyline that closely mirrors the resilience, connection, and emotional bonds formed at the South Florida Medical and Behavioral Health Institute senior center in Delray Beach.

JC Films Studios, known for producing more than 70 faith-based and family-oriented films, is bringing national visibility to this South Florida story. With Kevin Sorbo’s involvement, the film is expected to reach a broad audience and elevate awareness around senior loneliness as a growing public health concern.

As communities across the country search for solutions to senior isolation, the model created by South Florida Medical and Behavioral Health Institute in Delray Beach demonstrates how local programs can restore dignity, purpose, and human connection.

“This is bigger than a movie,” Kirshbaum added. “It’s about showing what’s possible when we invest in our seniors and refuse to let them face life’s hardest moments alone.”

Media outlets, community leaders, and organizations focused on aging and behavioral health are invited to follow the development of “The Gathering Place” and learn more about the Delray Beach senior center that inspired it.

Media Contact:
Media@sfmbhi.com

About South Florida Medical and Behavioral Health Institute

South Florida Medical and Behavioral Health Institute (SFMBHI) is a 501(c)(3) nonprofit organization dedicated to improving the health and well-being of individuals and families throughout South Florida. Based in Delray Beach, the organization provides integrated medical, behavioral health, and senior services, including a leading senior center focused on reducing isolation, improving wellness, and helping older adults rediscover purpose and connection. https://www.sfmbhi.org/

LOGO link for media: https://www.sfmbhi.org/assets/sfmbhi-logo.png

NEWS SOURCE: South Florida Medical and Behavioral Health Institute

This press release was issued on behalf of the news source (South Florida Medical and Behavioral Health Institute), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/kevin-sorbo-to-star-in-the-gathering-place-film-inspired-by-delray-beach-senior-center-helping-seniors-overcome-isolation/

Spodak Dental Group Introduces Affordable In-Office Membership Plan as Alternative to Rising Insurance Costs

DELRAY BEACH, Fla., April 2, 2026 (SEND2PRESS NEWSWIRE) — As healthcare costs continue to rise and many individuals reconsider their insurance options, Spodak Dental Group is offering a simple, transparent solution for maintaining dental health without the burden of traditional insurance. This is particularly helpful for those affected by increasing Affordable Care Act (ACA) premiums.

Image caption: Spodak Dental Group.

The SDG Plan, Spodak Dental Group’s in-office membership program, is designed for individuals and families seeking quality dental care at a predictable, affordable price. For just $31 per month for adults, members receive comprehensive preventive care and exclusive discounts on additional treatments, all without the complexities, limitations, or unexpected costs often associated with traditional dental insurance.

“At Spodak Dental Group, we understand that many people are making difficult financial decisions when it comes to healthcare,” Erika Pusillo, Spodak Dental Group CEO. “The SDG Plan was created to remove barriers to care and provide a straightforward, stress-free alternative that puts patients first.”

The Spodak Dental Group team knows that dental treatment can be expensive, and their goal is to help their family of patients keep their teeth for a lifetime, all while finding comfortable solutions for helping them fit any recommended dental treatment into their financial lifestyle. This is why the SDG Plan was created.

The SDG Membership Plan is not insurance, it’s better. Enrollees can expect to receive more benefits than limitations, and includes:

Low monthly cost of $31 for adults
Coverage for essential preventive services
Significant savings on additional dental treatments
No deductibles, no waiting periods, and no annual maximums
No claims, approvals, or insurance paperwork

With more individuals opting out of traditional insurance plans due to rising premiums, the SDG Plan offers a practical and accessible way to maintain oral health without compromise.

Spodak Dental Group remains committed to delivering high-quality, patient-centered care while adapting to the evolving needs of the community.

Patients ready to take control of their dental care are encouraged to enroll in the SDG Plan today and experience the benefits of affordable, hassle-free dentistry.

Call/text (561) 303-2413 or visit https://www.SpodakDental.com/ for more information and to sign up.

NEWS SOURCE: Spodak Dental Group

To view the original story, visit: https://www.send2press.com/wire/spodak-dental-group-introduces-affordable-in-office-membership-plan-as-alternative-to-rising-insurance-costs/

Hearing Loss Is a Brain Health Issue: Six Risks and What to Do About Them

Neuroscientist Dr. Kelly Tremblay Explains Why Protecting Hearing is Key to Brain Health in the New Brain Bytes Episode

BALTIMORE, Md., April 2, 2026 (SEND2PRESS NEWSWIRE) — Hearing loss affects one in three adults over age 65 and is a leading cause of years lived with disability worldwide. In its latest Brain Bytes micro-cast, AgingIN, a national leader advancing innovation in eldercare, features neuroscientist Kelly Tremblay, PhD, who highlights growing evidence that reframes hearing loss as a critical, and often overlooked, brain health issue.

Image caption: AgingIN, a national leader advancing innovation in eldercare, covers the importance of hearing loss and how it can affect brain health in its Brain Bytes micro-cast, featuring neuroscientist Dr. Kelly Tremblay.

“A powerful connection exists between hearing and brain health. Hearing is not just about sound. It is about cognition, connection, and long-term independence,” Tremblay says. “The good news is that hearing loss is not inevitable. In many cases, it’s preventable, detectable, and manageable.”

Over the past decade, research has advanced rapidly, reshaping how experts understand brain health. The focus is shifting from extending lifespan alone to actively protecting healthspan, and hearing is emerging as a key factor in maintaining cognitive vitality.

“Untreated hearing loss can lead to social withdrawal, early retirement, and reduced independence. Addressing it early helps individuals stay connected, active, and cognitively engaged,” continues Tremblay.

SIX DAILY STEPS TO PROTECT HEARING AS WE AGE:

Rethink hearing loss as a brain health issue.
Hearing loss does not just affect the ears. When the brain receives less sound input, the areas responsible for processing sound become damaged. Over time, this reduced stimulation prevents the brain from conveying and interpreting sound in a clear, meaningful way,even when sounds are made louder. Some research studies report hearing loss as a possible risk factor for dementia.
Do not assume hearing loss is inevitable.
A common misconception is that hearing loss simply comes with age. Tremblay emphasizes that lifestyle factors such as repeated exposure to loud noise, along with certain medical treatments, play a major role. Prevention starts earlier than most people think, beginning in our youth.
Watch for subtle early warning signs.
Hearing loss develops gradually, making it easy to miss. Often, others notice the changes before you do – because you might misunderstand what they said, or ask them to repeat themselves. Key indicators include difficulty following conversations, assuming others are mumbling and not speaking clearly, sensitivity to loud sounds (hyperacusis), and ringing in the ears (tinnitus).
Practice better “hearing hygiene” every day.
Protecting hearing is an ongoing habit. Reducing exposure to loud environments, being mindful of headphone volume, and addressing medical issues early can help preserve hearing over time. Small daily choices can have a long-term impact.
Get your hearing tested.
Testing is more accessible than many people realize. In addition to clinical evaluations, new options are available, such as online tools, mobile apps, and community-based screenings. Early detection is critical, not only to rule out medical concerns but also to maintain brain engagement.
Use the tools that keep you connected.
Hearing aids and assistive technologies can significantly improve your quality of life. Even though they don’t restore your hearing, because the ear and brain have been deprived of sounds for many years, they can still be very helpful. Traditional hearing aids and newer over-the-counter amplifiers can help you stay engaged in conversations, which is essential for brain health.

AgingIN continues the conversation at its annual conference, “Peak Purpose: Redefining How We Live and Age,” in Denver, August 10-13, where Tremblay will discuss the latest research on brain health and hearing with Dr. Shelly Chadha of the World Health Organization. Learn more: https://aginginnovation.org/events/annual-conference/

Brain Bytes, hosted by neuroscientist, audiologist, and World Health Organization advisor Dr. Kelly Tremblay, delivers quick, evidence-based insights that make brain science accessible and actionable. Drawing on more than 25 years of experience as a professor, researcher, advocate and clinician, Dr. Tremblay simplifies complex topics related to aging and brain health and shares them so people can age well.

ABOUT AGINGIN

MULTIMEDIA

IMAGE link for media: https://www.Send2Press.com/300dpi/26-0402-s2p-brainbytes-300dpi.webp

NEWS SOURCE: AgingIN

To view the original story, visit: https://www.send2press.com/wire/hearing-loss-is-a-brain-health-issue-six-risks-and-what-to-do-about-them/

Florida’s Best Hair Transplant Doctors: Drs. Harold Siegel and Matt Huebner Secure #1 Ranking for 2026

Ditching the traditional per-graft billing model, the renowned surgeons at Natural Transplants take the top spot in Your Health Magazine's annual evaluation, celebrated for their flat-rate pricing, VIP privacy, and High-Yield Unit Extraction (HUE) 'Mega-Sessions

FORT LAUDERDALE, Fla., March 24, 2026 (SEND2PRESS NEWSWIRE) — In an industry frequently complicated by complex per-graft pricing and high-volume clinical schedules, Drs. Harold Siegel and Matt Huebner of Natural Transplants have been officially recognized as the premier surgical team in the state. Your Health Magazine recently published its highly anticipated 2026 evaluations, placing Drs. Siegel and Huebner at the very top of their “Top 5 Most Trusted Hair Transplant Doctors in Florida” list.

Image caption: Dr. Matt Huebner (left) and Dr. Harold Siegel (right) of Natural Transplants, recently recognized as the #1 Hair Transplant Doctors in Florida for 2026 by Your Health Magazine.

The rigorous evaluation assessed top-rated surgeons across three core operational factors: pricing models, surgical yield, and patient privacy. The publication highlighted Drs. Siegel and Huebner’s unique concierge structure, which operates under a strict one-patient-at-a-time protocol. This dedicated approach ensures that individuals seeking hair transplants for men and women receive the undivided attention of the surgeon and the entire medical staff, resulting in a highly private, focused clinical environment.

“Our surgical philosophy has always been centered around the individual patient, not clinical volume,” said Dr. Matt Huebner, Chief Medical Officer. “By dedicating to just one patient at a time, we can safely move a large amount of hair to achieve exceptional density and natural results in a single sitting. We are incredibly honored to be recognized by Your Health Magazine, as it reinforces our unwavering commitment to operating as the best hair transplant doctor in Florida.”

Unlike standard hair restoration doctors that charge by the individual hair follicle, Drs. Siegel and Huebner were specifically commended for their upfront, flat-rate pricing. This model eliminates the financial guesswork of traditional “by-the-graft” billing, allowing patients to pay a single fee for the surgical session regardless of the exact graft count.

Furthermore, the hair restoration surgeons were recognized for their mastery of the High-Yield Unit Extraction (HUE) method. Designed specifically for “Mega-Sessions,” this surgical technique aims to safely harvest and transplant an exceptionally high volume of hair in one day. This maximizes density immediately, making it an ideal fit for patients looking to minimize the need for multiple future surgeries.

To read the comprehensive 2026 Florida patient guide, including the detailed review of Drs. Siegel and Huebner’s leading operational model and how they compare to other surgeons in the state, view the full list at: https://yourhealthmagazine.net/article/hair-care/top-5-most-trusted-hair-transplant-doctors-in-florida-for-2026-pricing-yield-privacy/.

About Drs. Harold Siegel and Matt Huebner:

Drs. Harold Siegel and Matt Huebner are board-certified physicians and the lead surgeons at Natural Transplants in Fort Lauderdale, Florida. Specializing exclusively in hair restoration, they are pioneers of the High-Yield Unit Extraction (HUE) method. By rejecting the industry-standard volume approach in favor of a one patient at a time concierge model, they provide unparalleled VIP privacy, transparent flat-rate pricing, and world-class surgical yield for patients traveling from across the globe. Learn more: https://naturaltransplants.com/.

MULTIMEDIA

Image link for media: https://www.Send2Press.com/300dpi/26-0324-s2p-matt-harold-300dpi.webp

Image caption: Dr. Matt Huebner (left) and Dr. Harold Siegel (right) of Natural Transplants, recently recognized as the #1 Hair Transplant Doctors in Florida for 2026 by Your Health Magazine.

NEWS SOURCE: Natural Transplants

To view the original story, visit: https://www.send2press.com/wire/floridas-best-hair-transplant-doctors-drs-harold-siegel-and-matt-huebner-secure-1-ranking-for-2026/

BioAustinCTX Announces Leadership Transition

AUSTIN, Texas, March 18, 2026 (SEND2PRESS NEWSWIRE) — BioAustinCTX today announced that Scott Collins, PhD, has transitioned from his role as President at the end of February after more than a decade of leadership supporting the growth of the Central Texas life sciences ecosystem.

Image caption: BioAustinCTX.

During his tenure over the past decade, Dr. Collins helped guide BioAustinCTX through a period of significant expansion for the region’s biotechnology and life science community. Under his leadership, the organization strengthened its role as a connector across startups, established companies, academic institutions, investors, and economic development partners, helping foster collaboration and visibility across the ecosystem.

“Serving as President of BioAustinCTX has been one of the great privileges of my professional career,” said Dr. Collins. “I am proud of the progress our community has made and look forward to continuing to support the organization as Ambassador and Past President while focusing on advancing deep technology and biotechnology innovation in the Central Texas region.”

Following this transition, Dr. Collins will remain actively engaged with BioAustinCTX in an Ambassador and Past President capacity, supporting the organization’s mission and ongoing initiatives.

As BioAustinCTX looks ahead, the organization remains focused on strengthening the connectivity, competitiveness, and growth of the Central Texas life sciences sector. The Board of Directors is committed to building on the strong foundation established to date and will share additional updates regarding leadership and strategic priorities in the coming weeks.

BioAustinCTX thanks Dr. Collins for his service and leadership and looks forward to continued collaboration as the organization enters its next phase.

About BioAustinCTX

BioAustinCTX is a nonprofit industry organization dedicated to advancing the life sciences ecosystem in Central Texas. Through collaboration, education, networking, and strategic engagement, BioAustinCTX supports entrepreneurs, researchers, companies, and partners working to bring life-changing technologies to market. Learn more at https://bioaustinctx.com/.

NEWS SOURCE: BioAustinCTX

This press release was issued on behalf of the news source (BioAustinCTX), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/bioaustinctx-announces-leadership-transition/

ScoopCloud

The affordable PR newswire service

Tag Archives: Health and Medical

Zeteo Biomedical Expands into Pulmonary Drug Delivery with AriesMR Active Dry Powder Inhaler

Hemophilia Association of New Jersey Unveils Bold New Brand, Redesigned Website, and Announces Its Annual Bleeding Disorders Awareness 5K Run and 1-Mile Walk

3Aware and John Snow Labs Announce Partnership to Deliver Multimodal De-Identification Inside the 3Aware Evidence Vault

New Memoir ‘Me, Mom & the Monster’ Shines Light on Huntington’s Disease

New Cadence Healthcare Welcomes Dr. Karen Rasmussen as Third Physician, Reuniting Three Doctors from the Same Long Beach Residency Program

NeuroDex ExoSORT Platform Demonstrates Treatment-Responsive Blood-Based Measurement of Neuronal TDP-43 in People Living with ALS

Jabber Jaw Kids Toothpaste, LLC Introduces ‘Smile Paint’ – A Play-Based Toothpaste Concept That Turns Toothbrushing into a Creative Adventure

Florida Attorney General Uthmeier Becomes First in Nation to Subpoena CVS’s Secret Contracts with Drug Manufacturers, Distributors, and Pharmacies

Simpson Spotlights a More Connected Approach to Memory Care for Alzheimer’s and Brain Awareness Month

Breakthrough At-Home Vision Testing Platform Reinvents the Eye Exam with MIT Science and Telehealth

New Research: Healthspan Is a Growing Priority for Senior Living

Natural Transplants and Cherry Announce Strategic Partnership and Release Exclusive 2026 Guide to Hair Transplant Cost in the U.S.

Millions Dream of Having Children: World Fertility Project Expands Global ‘Break the Taboo’ Campaign to Address Stigma and Barriers to Care

Montgomery County Neurological Center Urges Patients with Dizziness, Balance Disorders, Parkinson’s Disease, and Movement Conditions to Seek Specialized Physical Therapy

Family United Home Health Care Launches New Website to Improve Access to Care Services Across Missouri

MyBioSource Now Offers One of the Largest ELISA Kit Collections Available to Researchers Globally

Spodak Dental Group Recognized as a 2026 Sun Sentinel Top Workplace for the 10th Time

99 New Pharmaceutical Biotechnology and Healthcare Projects Drive Major Facility Investments in April 2026

AAAbio Enhances Global Diagnostic Research Capabilities Through Strategic Local Distribution Networks

The Jackson Copeland Foundation Awarded $10,000 Grant from Duke Energy Foundation as Part of Commitment to Support Communities Across Florida

New Residential Facility Opens in Clayton County, Bringing Much-Needed Addiction Treatment Access to South Atlanta

Neurotech Reports Announces Thomas Stieglitz, Ph.D., as Keynote Speaker for the Second Annual Neurotech Leaders Forum imec

Amba to Highlight Real-World Results in Webinar on Proactive, AI-Enabled Care

AgingIN Opens Registration for Longevity Pre-Summit and 2026 Conference ‘Peak Purpose: Redefining How We Live and Age’

Maryland RN Launches Platform to Close the Home Care Affordability Gap – Without Sacrificing the Standard Families Demand

Legacy Dental: Your Trusted Partner for Dental Emergencies

Caregiving Is Personal for Many Simpson Team Members

Caregiving Is Personal for Many Simpson Team Members

RespondWell Launches First Telemedicine Platform Built Exclusively for First Responders

ViewTech Borescopes to Demonstrate Clean-In-Place Visual Inspection Solutions at INTERPHEX 2026

Kevin Sorbo to Star in ‘The Gathering Place,’ Film Inspired by Delray Beach Senior Center Helping Seniors Overcome Isolation

Spodak Dental Group Introduces Affordable In-Office Membership Plan as Alternative to Rising Insurance Costs

Hearing Loss Is a Brain Health Issue: Six Risks and What to Do About Them

Florida’s Best Hair Transplant Doctors: Drs. Harold Siegel and Matt Huebner Secure #1 Ranking for 2026

BioAustinCTX Announces Leadership Transition